WO2021174331A1 - Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens - Google Patents

Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens Download PDF

Info

Publication number
WO2021174331A1
WO2021174331A1 PCT/CA2020/051059 CA2020051059W WO2021174331A1 WO 2021174331 A1 WO2021174331 A1 WO 2021174331A1 CA 2020051059 W CA2020051059 W CA 2020051059W WO 2021174331 A1 WO2021174331 A1 WO 2021174331A1
Authority
WO
WIPO (PCT)
Prior art keywords
light source
uvc
uva
uvc light
pathogen
Prior art date
Application number
PCT/CA2020/051059
Other languages
French (fr)
Inventor
Andrew Clark Baird AUBERT
Original Assignee
Helios Shield Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helios Shield Ltd filed Critical Helios Shield Ltd
Priority to CA3172386A priority Critical patent/CA3172386A1/en
Priority to JP2022552252A priority patent/JP2023526715A/en
Priority to KR1020227034267A priority patent/KR20220149731A/en
Priority to EP20922533.3A priority patent/EP4114472A4/en
Priority to PCT/CA2021/050543 priority patent/WO2021223012A1/en
Priority to CA3177202A priority patent/CA3177202A1/en
Priority to US17/299,378 priority patent/US20230063654A1/en
Priority to EP21799470.6A priority patent/EP4146289A1/en
Publication of WO2021174331A1 publication Critical patent/WO2021174331A1/en
Priority to ZA2022/09673A priority patent/ZA202209673B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/10Ultraviolet radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029Radiation
    • A61L2/0047Ultraviolet radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/24Apparatus using programmed or automatic operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10Apparatus features
    • A61L2202/11Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10Apparatus features
    • A61L2202/14Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/25Rooms in buildings, passenger compartments

Definitions

  • UVA COMBINATION ULTRA-VIOLET A
  • UVC ULTRA-VIOLET C
  • This disclosure relates to a system and method of reducing and inhibiting growth of pathogens, in public areas such as areas frequented by humans in public transit vehicles and the like, by the use of UVA and UVC light sources at levels detrimental to pathogens but safe for animals, including mammals and humans.
  • UVC light sources are known to be very effective in reducing bacteria levels on surfaces.
  • the typical radiated power and exposure time needed to reduce the levels of bacteria may be deleterious to human eyes and epidermis and dermis layers.
  • an alterating UVA/UVC system for reducing and inhibiting further growth, on a surface, of at least one pathogen, wherein said system has no deleterious effects on an animal, including a human, in particular on a human eye or epidermis and dermis, wherein said system comprises: i) at least one UVA light source; ii) at least one UVC light source; and iii) at least one controller connected to each of said at least one UVA light source and said at least one UVC light source, for controlling at least one parameter of each of said UVA light source and UVC light source selected from light source, light intensity, radiated power level, wavelength, exposure time and combinations thereof; wherein said at least one UVC light source emits UVC light to a surface for a period of time reducing the level of said pathogen on said surface to a level that is safe to animals including humans, and said at least one UVA light source emits UVA light to a surface for a period of time inhibiting growth
  • said at least one UVC light source has an operating wavelength of from about 275 nanometers (nm) to about 295 nm. In one alternative, said at least one UVC light source has an operating wavelength of about 275 nm.
  • said at least one UVA light source has an operating wavelength of from about 385 nm to about 405 nm. In one alternative, said at least one UVA light source has an operating wavelength of about 405 nm
  • said at least one UVC light source is a light emitting diode (LED).
  • said at least one UVA light source is a
  • the at least one controller automatically cycles between emitting light from said at least one UVA light source and from said at least one UVC light source.
  • said at least one UVC light source has an emission at a power level and time duration to reduce pathogen levels on a surface exposed to said at least one UVC light source.
  • the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.
  • the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.
  • said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.
  • said at least one UVC light source has a power rating of from about 10 mW to about 100 W. In one alterative, said at least one UVC light source has a power rating of 244 mW.
  • said at least one UVA light source has a power rating of from about 10 mW to about 100 W. In one alternative, said at least one UVA light source has a power rating of 20 mW.
  • said system reduces the level of pathogens on a surface exposed to said system by 1 to about 100%. In one alterative, by 10 to about 20%.
  • a method of reducing levels, on a surface, and inhibiting further growth of at least one pathogen, on said surface wherein said method has no deleterious effects on an animal, including a human, in particular on a human eye or epidermis and dermis, wherein said method comprises: i) Exposing said surface to at least one UVC light source for a period of time to reduce the level of least one pathogen on said surface; ii) Terminating the exposure of the at least one UVC light source on said surface; iii) Exposing said UVC exposed surface to at least one UVA light source for a period of time to inhibit growth of least one pathogen on said surface; iv) Terminate the exposure of the at least one UVA light source on said surface; v) Optionally repeating steps i) to
  • said at least one UVC light source has an operating wavelength of from about 275 nanometers (run) to about 295 run. In one alternative, said at least one UVC light source has an operating wavelength of about 275 run. [00019] According to one alternative, said at least one UVA light source has an operating wavelength of from about 385 run to about 405 run. In one alternative, said at least one UVA light source has an operating wavelength of about 405 run.
  • said at least one UVC light source is a light emitting diode (LED).
  • said at least one UVA light source is a LED.
  • steps i) to iv) are controlled by at least one controller automatically cycling between emitting light from said at least one UVA light source and from said at least one UVC light source.
  • said at least one UVC light source has an emission at a power level and time duration to reduce at least one pathogen on a surface exposed to said at least one UVC light source.
  • the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.
  • the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.
  • said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.
  • said at least one UVC light source has a power rating of from about 10 mW to about 100 W. In one alterative, said at least one UVC light source has a power rating of 244 mW.
  • said at least one UVA light source has a power rating of from about 10 mW to about 100 W. In one alternative, said at least one UVA light source has a power rating of 20 mW.
  • said method reduces the level, and in another alternative inhibits growth, of at least one pathogen on a surface by 1 to 100%.
  • said method reduces the level, and in another alternative inhibits growth, of at least one pathogen on a surface by 1 to 100%.
  • said method includes a UVC time interval of UVC on from 1 sec to 300 sec (wherein the UVA would be off), and a UVA on from lh to 10 days (wherein the UVC would be off).
  • the UVC on/off UVA on/off time intervals will depend on factor such as: power rating of the UV light source; pathogens targeted; location of pathogens; levels of pathogens; type of pathogens.
  • the UVA light source may remain on at levels safe to animals including humans to inhibit pathogen growth and UVC is turned on at intervals to reduce pathogen levels should pathogen growth inhibition meet its limit, if any.
  • pathogen may include bacteria, viruses, yeast, protozoa, mould and combinations thereof.
  • said pathogen is selected from the group consisting of E. Coli K12, S. Epidermis and B. Subtilis.
  • surface includes surfaces typically found in public places such as bathrooms and kitchens, including but not limited to countertops, hard counters, wood counters, concrete, plastic, rubber, leather, material and the like.
  • Figure 1 is a block diagram of the system, according to one alternative.
  • Figure 2 is a block diagram of the system, according to another alterative.
  • FIG. 1 there is depicted a block diagram of a single Pulse Width Modulation (PWM) example for the system described herein.
  • a PWM generator 10 generates a single continuous PWM which feeds into two circuits.
  • the first circuit is an optional logic buffer circuit 20 for controlling the pulsing of the UVC emitter 40.
  • the logic buffer circuit 20 ensures that the UVC emitter 40 is emitting when the PWM generator 10 is outputting a high logic level, and off when the PWM generator 10 is outputting a low logic level. See the output curve 22.
  • the second circuit is a logic inverter 30 controlling the UV A emitter 50, ensuring that the UV A emitter is off when the PWM generator 10 is outputting a high logic level, and UVA emitter is on when the PWM generator 10 is outputting a low logic level. See the inverted output curve 32.
  • FIG. 2 there is depicted a block diagram of a timer controlled system, according to one alternative.
  • a UVC timer circuit 100 and a UVA timer circuit 200 each controlling the UVC emitter 40 and UVA emitter 50 respectively.
  • the UVC timer circuit 100 is set for 150 seconds on and the UVA timer circuit 200 is set for 6 hours.
  • the UVC timer circuit 100 is enable and outputs a logic high which is fed into a first logic buffer 110 and first logic inverter 120.
  • the first logic buffer 110 controls the UVC emitter 40 to be on, while the first logic inverter 120 is used to ensure the UVA timer circuit 200 is off.
  • UVC timer circuit 100 completes the 150 seconds
  • the output changes state to turn off the UVC emitter 40 and turn on the UVA timer circuit 200 for 6 hours.
  • UVA timer circuit 200 outputs a logic high which is fed into a second logic buffer 130 and second logic inverter 140.
  • the second logic buffer 130 controls the UVA emitter 50 to be on, while the second logic inverter 140 is used to ensure the UVC timer circuit 100 is off.
  • the output changes state to turn off the UVA emitter 50 and turn on the UVC timer circuit 100 which turns on the UVC emitter 40 for 150 seconds, and the cycle repeats as required.
  • the time value of each time will be determined by a variety of factors including pathogen to be eliminated, power level of UV light source, size of room, etc.
  • FLS UV Tool program was used to calculate the effect of UVC LEDS on reducing bacteria levels in an enclosed space measuring 3 metres x 3 metres x 3 metres.
  • Nine (9) UVC LEDs each having a wavelength of 275 nm and a power rating of 244.2 mW were tested for 20% bacteria reduction and safety to human eyes and skin at various distances (floor level, 2 meters above floor level) from the light source on the ceiling (3 metres from the floor) of the enclosed space.
  • Each UVC LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVC LEDs and each UVC LED having a radiating angle of light source of 135° (FWHM*).
  • the LED beam angle measures the usable light emitted from an LED source.
  • one of two methods is used to define the beam angle; the first looks for the angle at which 50% of the peak intensity is readied on either side of the origin. The second looks for the angle at which 10% of the peak intensity is reached on each side of the origin.
  • Most commonly used is the Full Width, Half Maximum (FWHM) relating to 50% intensity, if for example an LED was measured to have 50% intensity at 15° it’s viewing angle (FWHM) would be 30°.
  • Bacillus magaterium sp. (veg.) 29.41s
  • UVC alone required 9 minutes and 3 seconds to reduce all bacteria by 20%.
  • Human safety levels maximum exposure time were also measured at 1 metre from light source for wavelengths that include the UVC LED wavelength studied.
  • UVA LEDs each having a wavelength of 405 nm and a power rating of 1000 mW were tested for reducing bacteria growth at levels safe to human eyes and skin at various distances (floor level, 1 meter above floor level, 2 meters above floor level) from the light source in a test room size of 3 metres by 3 metres by 3 metres for a duration of 40 hours.
  • Each UVA LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVA LEDs and each UVA LED having a radiating angle of light source of 120° (full width half max).
  • Bacillus magaterium sp. (veg.) 98.38% 2h 10m 58s
  • Safety level were measured at 1 metre from light source.
  • UVA alone for reduction exceeds safety limits at 7 min and 45 secs.
  • FLS UV tool software program was used to calculate the effect of UVC LEDS in a pulsing fashion (on for a period of time, off for a period of time) on reducing bacteria levels in an enclosed space measuring 3 metres x 3 metres x 3 metres.
  • UVC LEDs each having a UVC wavelength of 275 nm and a power rating of 244.2 mW were tested for 20% bacteria reduction and safety to human eyes and skin at various distances (floor level, 2 meters above floor level) from the light source on the ceiling (3 metres from the floor) of the enclosed space.
  • Each UVC LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVC LEDs and each UVC LED having a radiating angle of light source of 135° (FWHM) and pulsed on for 150 sec at a time and pathogen levels were measured. Then the time required for 20% reduction was calculated based on the % reduction at 150 secs.
  • FWHM radiating angle of light source
  • Poliovirus - Poliomyelitis 35.02% 1m 17s
  • Safety levels were measured at 1 metre from light source.
  • FLS UV tool software program was used to calculate the effect of UVA LEDS in a pulsing fashion (on for a period of time, off for a period of time) on inhibiting bacteria levels in an enclosed space measuring 3 metres x 3 metres x 3 metres after exposure to UVC as per example 3 above.
  • UVC LEDs each having a UVA wavelength of 405 nm and a power rating of 20 mW were tested for growth inhibition and safety to human eyes and skin at various distances (floor level, 2 meters above floor level) from the light source on the ceiling (3 metres from the floor) of the enclosed space.
  • Each UVA LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVA LEDs and each UVA LED having a radiating angle of light source of 120° (FWHM) and pulsed on for 6 hours at a time (alternating with UVC pulsing) and pathogen levels were measured.
  • FWHM radiating angle of light source
  • Staphylococcus aureus 368% Staphylococcus hemolyticus 0.56%
  • UVC when the UVC is pulsed on, the bacteria is killed to a certain level and UVC is pulsed off with UVA pulsed on keeping the bacteria level the same without any growth.
  • the UVA is then pulsed off and UVC is pulsed on with further bacteria kill and subsequent UVA on after UVC is off maintains the new lower level of bacteria on the surface (i.e. further growth inhibition.
  • the ON/OFF pulsing method reduces the level of bacteria on the surface by about 20% between 12-18 hours and inhibits bacteria growth for at least 24 hours while keeping radiation levels safe for humans.
  • ATP Adenosine triphosphate
  • CFU Colony forming unit
  • RLU Relative luminescence units
  • SEM Standard error of the mean
  • TNTC Too numerous to count, UVA; Ultraviolet A, UVC; Ultraviolet C.
  • Nutrient agar, maximum recovery diluent, violet red bile glucose agar and tryptone soya broth was purchased from Oxoid Ltd (Basingstoke, Hampshire UK). Petri dishes were purchased from Scientific Lab Supplies Ltd UK. UltraSnap 1 M Adenosine triphosphate (ATP) surface tests were purchased from Hygiena International Ltd. E. Coli K12 was purchased from Blades Biological Ltd (Eastshire, UK).
  • the equipment was housed in a Syngene Bioimaging light box for protection of exposure to UVA and UVC.
  • the wire from the lamp was wrapped around the clamp stand in order to ensure that the lamp was frilly exposing the petri dish.
  • the lamp was placed 32cm away from the petti dish.
  • the lamp and control box were provided by Helios.
  • the autoclave was an Eclipse 17 and a Genlab incubator was used for organism growth. The temperature of the box was maintained at room temperature. A Hygiena luminometer was used for ATP readings.
  • Test organism was E. Coli K12.
  • Agar was sterilised at 121°C. The organism was grown in tryptone soya broth and incubated for 12 hours at 37°C.
  • E. Coli K12 was validated using violet red bile glucose agar. Maximal recovery diluent was autoclaved prior to use.
  • E. Coli K12 was diluted to 1 in 10,000 in maximal recovery diluent in order to be counted using a lawn plate approach. 10 ⁇ L of E. Coli K12 was pipetted in four different areas on the nutrient three agar plate in sterile conditions. The plates were then stored in one of three conditions: dark, natural light and UV light. The details regarding the UV light exposure are recorded in Protocol I and Protocol II. After exposure, plates were incubated for 24 hours at 37°C and colonies were counted.
  • UVA nominal wavelength of 405nm
  • UVC nominal wavelength of 275nm
  • ATP measurements were conducted in instances where no visible colonies were present.
  • the UltraSnapTM swabs were equilibrated at room temperature. The surface of the petri dish was swabbed thoroughly. The swab was replaced back into the tube and the tube was placed into the Hygiena luminometer within 30 seconds and ATP levels were recorded. Readings less than 10 relative luminescence units (RLU) are considered clean. Readings between 11-29 RLU indicate a warning and readings above 30 RLU indicate a dirty surface.
  • RLU relative luminescence units
  • Colony forming units are counted based on the number of viable bacterial cells. This is undertaken with the aid of a microscope. The number of bacteria per mL of sample is calculated by dividing the colony number by the dilution factor employed. This is a direct count method.
  • Protocol ⁇ A 32 ⁇ 3% reduction in bacterial load across a 13 iteration repeat of 33 minute irradiation cycles (Protocol ⁇ ) is shown. Additionally, Protocol II compared to controls exposed to natural light and dark elicited a 35 ⁇ 12% reduction in bacterial load.
  • This example investigated UVA and UVC irradiation on an array of bacteria considering a variety of power settings and times, the impact of UVA and UVC pulsing on an array of bacteria considering a variety of distances and exposure times and to use modelling in order to establish cross contamination risk following exposure with UV light.
  • the equipment was housed in a Syngene Bioimaging light box for protection of exposure to UVA and UVC.
  • the wire from the lamp was wrapped around the clamp stand in order to ensure that the petti dish was fully exposed to the lamp.
  • the lamp was placed 32cm away from the petti dish for all experiments with exception to where different distances are stated.
  • the lamp and control were provided by Helios Shield Ltd. UVA and UVC exposure dials were utilised for direct exposure. The control stated a total of 16 different settings for the lamp.
  • This apparatus assembly was constructed in Nottingham Trent University, UK
  • the autoclave (Eclipse 17) was utilised in order to sterilise all equipment and a Genlab incubator was used for organism growth which was maintained at 37°C throughout the experiment period.
  • the temperature of the box was maintained at room temperature which fluctuated between 18°C and 25°C.
  • a Hygiena luminometer was used for ATP readings.
  • Test organisms include E. Coli K12, B. Subtilis and S. Epider midis. Nutrient agar and violet blue red agar were prepared, as per the protocol from the manufacturer, and was sterilised at 121°C and 110.4 kPa for a 1 hour period. Both types of agar were poured into singlet vent petri dishes, left to dry and set before being stored at 4°C prior to use. Organisms (B. Subtilis and S. Epidermidis) were grown in tryptone soya broth and incubated for 12 hours at 37°C. E. Coli K12 was validated using violet red bile glucose agar using the streaking method. B. Subtilis and S.
  • Epidermidis were validated using the Nutrient agar. Maximal recovery diluent was autoclaved prior to use. E. Coli K12, B. Subtilis and S. Epidermidis was diluted to 1 in 10,000 in maximal recovery diluent in order to be counted using a lawn plate approach. 10 ⁇ L of E. Coli K12 was pipetted in different areas on the nutrient three nutrient agar plates under sterile conditions. The plates were then stored in one of three conditions: dark, natural light and UV light for different periods of time. The details regarding the UV light exposure, time of exposure and distance from the UV lamp are recorded in Protocol I and Protocol ⁇ below. After exposure, plates were incubated for 24 hours at 37°C and colonies were counted. In the instances where the bacteria was too numerous to count (TNTC), ATP measurements were performed.
  • UVA and UVC were used simultaneously on the agar plates for a period of 12 hours using various power levels including 42mW, 117mW and 65mW. This was performed for all microorganisms in the investigation, E. Coli K12, B. Subtilis and S. Epidermidis. The bacteria were then grown for a 24 hour period and data was acquired.
  • UVA and UVC were pulsed using power levels 42mW and 65mW, respectively. UVC was engaged for 3 minutes, then UVC was disengaged. Subsequently UVA was engaged for 30 minutes and then UVA was disengaged. This was completed for a total of 10-13 iterations with a total exposure time between 270 minutes and 399 minutes, respectively. The bacteria were then grown for a 24 hour period and data was acquired. This was performed for E. Coli K12 and S. Epidermidis strains.
  • ATP measurements were conducted in instances where no colonies were visible on the agar plates or bacteria colonies were TNTC.
  • the UltraSnap ⁇ swabs were equilibrated at room temperature (storage for UltraSnap TM swabs are at 21 °C).
  • the surface of the petri dish was swabbed thoroughly, specifically the centre of the plate where bacteria had been pipetted directly.
  • the swab was replaced back into the tube and the liquid-stable reagent from the UltraSnapTM swab was added.
  • the purpose of the addition of the liquid-stable reagent is to facilitate the bioluminescence reaction and optimises sample recovery.
  • the unique liquid-stable reagent gives superior sensitivity and reliable results, with a sensitivity stated of O.OOlfinol.
  • the tube was placed into the Hygiena luminometer within 30 seconds and ATP levels were recorded using a new solid-state photodiode.
  • Photodiodes have the ability to detect and quantify low levels of light. The light emitted is in direct proportion to the amount of ATP present in the sample. Readings less than 10 relative luminescence units (RLU) are considered clean. Readings between 11-29 RLU indicate a warning and readings above 30 RLU indicate a dirty surface. Food manufacturing and healthcare settings both use ATP to determine whether surfaces are clean or not.
  • Dose-response model have been derived in order to assess the cross- contamination risk. This modelling helps in the understanding of exposure to pathogens and is crucial in risk assessments (Haas, C. N. (2015) Microbial Dose Response Modeling: Past, Present and Future. Environment Science and Technology 49 1245-1259). An exponential distribution has been developed (Watanabe, T. et al. (2010) Development of a Dose-Response Model for SARS Coronavirus. Risk Analysis 30 7) and is classified as a Generation 1 model i.e. a model that describes the probability of response to exposed dose (Haas 2015).
  • p(d) is the risk of illness at the dose of d and k is a parameter specific for the pathogen (Watanabe et al. 2010).
  • Parameter k is the probability that a single pathogen will initiate the response (Watanabe et al. 2010).
  • Parameter k is developed for each microorganism (Watanabe et al. 2010). This exponential model will be applied in order to assess the cross-contamination risks.
  • Table 4 Measurements of ATP in RLU in dark, natural light and UV light conditions using different power levels for UVA and UVC, F, 42mW and 65mW, for different strains, E. Coli K12, S. Epidermis and/?. Subtilis.
  • UVA exposure UVA exposure. These values may change considering different intensities.
  • RNA which is specifically important for viruses.
  • the effectiveness of UV has been demonstrated in other virus models such as influenza (Nishisaka-Nonaka, R. et al. (2016) Irradiation by ultraviolet light-emitting diodes inactivates influenza a viruses by inhibiting replication and transcription of viral RNA in host cells Journal of Photochemistry and Photobiology B: Biology 189 193-200).
  • coronavimses specifically MERS-CoV
  • MERS-CoV Middle East respiratory syndrome coronavirus
  • a pulsed UVA and UVC sequence has the capability to reduce bacterial loadings, using specifically E. Coli K12, S. Epidermis and B. Subtilis.
  • a reduction in ATP was observed considering 12-hour exposure times using UVA and UVC to all strains using different combinations of power levels, more specifically 65 mW (UVC), 42mW(UVA) and 117mW (UVC).
  • pulse experiments using UVA at 42mW and UVC at 65 mW revealed a reduction in E. Coli K12 and S. Epidermis at a 32cm distance comparatively to natural light and dark settings.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

A UVA/UVC system for reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said system includes: iv) at least one UVA light source; v) at least one UVC light source; and at least one controller connected to each of the at least one UVA light source and the at least one UVC light source, for controlling at least one parameter of each of the UVA light source and UVC light source.

Description

TITLE OF THE INVENTION
COMBINATION ULTRA-VIOLET A (UVA) AND ULTRA-VIOLET C (UVC) SYSTEM FOR REDUCTION AND INHIBITION OF GROWTH OF PATHOGENS
FIELD OF THE DISCLOSURE
[0001] This disclosure relates to a system and method of reducing and inhibiting growth of pathogens, in public areas such as areas frequented by humans in public transit vehicles and the like, by the use of UVA and UVC light sources at levels detrimental to pathogens but safe for animals, including mammals and humans.
BACKGROUND
[0002] UVC light sources are known to be very effective in reducing bacteria levels on surfaces. However, the typical radiated power and exposure time needed to reduce the levels of bacteria may be deleterious to human eyes and epidermis and dermis layers.
[0003] There is a need for a system which will reduce the level of bacteria on a surface and inhibit further growth while being safe to human exposure.
SUMMARY
[0004] According to one aspect, there is provided an alterating UVA/UVC system for reducing and inhibiting further growth, on a surface, of at least one pathogen, wherein said system has no deleterious effects on an animal, including a human, in particular on a human eye or epidermis and dermis, wherein said system comprises: i) at least one UVA light source; ii) at least one UVC light source; and iii) at least one controller connected to each of said at least one UVA light source and said at least one UVC light source, for controlling at least one parameter of each of said UVA light source and UVC light source selected from light source, light intensity, radiated power level, wavelength, exposure time and combinations thereof; wherein said at least one UVC light source emits UVC light to a surface for a period of time reducing the level of said pathogen on said surface to a level that is safe to animals including humans, and said at least one UVA light source emits UVA light to a surface for a period of time inhibiting growth of said pathogen on said surface, such that during the time said at least one UVC light source and said at least one UVA light source is emitting on said surface, radiation levels from said at least one UVC light source and said at least one UVA light source is safe to animals, including humans; wherein when said at least one UVC light source is emitting UVA light to said surface, said at least one UVC light is off, and when said at least one UVA light source is emitting light to said surface, said at least one UVC light source is off; wherein cycling between said at least one UVC light source and said at least one UVA light source is controlled by said at least one controller.
[0005] According to one alternative, said at least one UVC light source has an operating wavelength of from about 275 nanometers (nm) to about 295 nm. In one alternative, said at least one UVC light source has an operating wavelength of about 275 nm.
[0006] According to one alternative, said at least one UVA light source has an operating wavelength of from about 385 nm to about 405 nm. In one alternative, said at least one UVA light source has an operating wavelength of about 405 nm
[0007] According to yet another alternative, said at least one UVC light source is a light emitting diode (LED).
[0008] According to yet another alternative, said at least one UVA light source is a
LED.
[0009] In one alternative, the at least one controller automatically cycles between emitting light from said at least one UVA light source and from said at least one UVC light source.
[00010] In one alternative, said at least one UVC light source has an emission at a power level and time duration to reduce pathogen levels on a surface exposed to said at least one UVC light source.
[00011] In one alternative, the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.
[00012] In one alternative, the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.
[00013] In one alternative, said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.
[00014] In one alternative, said at least one UVC light source has a power rating of from about 10 mW to about 100 W. In one alterative, said at least one UVC light source has a power rating of 244 mW.
[00015] In one alternative, said at least one UVA light source has a power rating of from about 10 mW to about 100 W. In one alternative, said at least one UVA light source has a power rating of 20 mW.
[00016] In one alternative, said system reduces the level of pathogens on a surface exposed to said system by 1 to about 100%. In one alterative, by 10 to about 20%. [00017] In yet another alternative, there is provided a method of reducing levels, on a surface, and inhibiting further growth of at least one pathogen, on said surface, wherein said method has no deleterious effects on an animal, including a human, in particular on a human eye or epidermis and dermis, wherein said method comprises: i) Exposing said surface to at least one UVC light source for a period of time to reduce the level of least one pathogen on said surface; ii) Terminating the exposure of the at least one UVC light source on said surface; iii) Exposing said UVC exposed surface to at least one UVA light source for a period of time to inhibit growth of least one pathogen on said surface; iv) Terminate the exposure of the at least one UVA light source on said surface; v) Optionally repeating steps i) to iv) in order to maintain a desired level of the least one pathogen, on said surface.
[00018] In one alternative, said at least one UVC light source has an operating wavelength of from about 275 nanometers (run) to about 295 run. In one alternative, said at least one UVC light source has an operating wavelength of about 275 run. [00019] According to one alternative, said at least one UVA light source has an operating wavelength of from about 385 run to about 405 run. In one alternative, said at least one UVA light source has an operating wavelength of about 405 run.
[00020] According to yet another alternative, said at least one UVC light source is a light emitting diode (LED).
[00021] According to yet another alterative, said at least one UVA light source is a LED. [00022] In one alternative, steps i) to iv) are controlled by at least one controller automatically cycling between emitting light from said at least one UVA light source and from said at least one UVC light source.
[00023] In one alternative, said at least one UVC light source has an emission at a power level and time duration to reduce at least one pathogen on a surface exposed to said at least one UVC light source.
[00024] In one alterative, the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.
[00025] In one alternative, the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.
[00026] In one alternative, said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.
[00027] In one alternative, said at least one UVC light source has a power rating of from about 10 mW to about 100 W. In one alterative, said at least one UVC light source has a power rating of 244 mW.
[00028] In one alternative, said at least one UVA light source has a power rating of from about 10 mW to about 100 W. In one alternative, said at least one UVA light source has a power rating of 20 mW.
[00029] In one alternative, said method reduces the level, and in another alternative inhibits growth, of at least one pathogen on a surface by 1 to 100%. In one alterative, by at least one of the following ranges: 10 to 20%, 20 to 30%, 30 to 40%, 40 to 50%, 50 to 60%, 60 to 70%, 70 to 80%, 80 to 90% and 90 to 100%.
[00030] In one alternative, said method includes a UVC time interval of UVC on from 1 sec to 300 sec (wherein the UVA would be off), and a UVA on from lh to 10 days (wherein the UVC would be off). The UVC on/off UVA on/off time intervals will depend on factor such as: power rating of the UV light source; pathogens targeted; location of pathogens; levels of pathogens; type of pathogens.
[00031] In one alternative, the UVA light source may remain on at levels safe to animals including humans to inhibit pathogen growth and UVC is turned on at intervals to reduce pathogen levels should pathogen growth inhibition meet its limit, if any.
[00032] Herein the term pathogen may include bacteria, viruses, yeast, protozoa, mould and combinations thereof.
[00033] In one alternative, said pathogen is selected from the group consisting of E. Coli K12, S. Epidermis and B. Subtilis.
[00034] Herein the term surface includes surfaces typically found in public places such as bathrooms and kitchens, including but not limited to countertops, hard counters, wood counters, concrete, plastic, rubber, leather, material and the like.
BRIEF DESCRIPTION OF THE FIGURES
[00035] Figure 1 is a block diagram of the system, according to one alternative.
[00036] Figure 2 is a block diagram of the system, according to another alterative.
DETAILED DESCRIPTION
[00037] Referring now to FIG. 1, there is depicted a block diagram of a single Pulse Width Modulation (PWM) example for the system described herein. A PWM generator 10 generates a single continuous PWM which feeds into two circuits. The first circuit is an optional logic buffer circuit 20 for controlling the pulsing of the UVC emitter 40. The logic buffer circuit 20 ensures that the UVC emitter 40 is emitting when the PWM generator 10 is outputting a high logic level, and off when the PWM generator 10 is outputting a low logic level. See the output curve 22. The second circuit is a logic inverter 30 controlling the UV A emitter 50, ensuring that the UV A emitter is off when the PWM generator 10 is outputting a high logic level, and UVA emitter is on when the PWM generator 10 is outputting a low logic level. See the inverted output curve 32.
[00038] Referring now to FIG. 2, there is depicted a block diagram of a timer controlled system, according to one alternative. In this example, there is a UVC timer circuit 100 and a UVA timer circuit 200 each controlling the UVC emitter 40 and UVA emitter 50 respectively. The UVC timer circuit 100 is set for 150 seconds on and the UVA timer circuit 200 is set for 6 hours. During start up, the UVC timer circuit 100 is enable and outputs a logic high which is fed into a first logic buffer 110 and first logic inverter 120. The first logic buffer 110 controls the UVC emitter 40 to be on, while the first logic inverter 120 is used to ensure the UVA timer circuit 200 is off. Once the UVC timer circuit 100 completes the 150 seconds, the output changes state to turn off the UVC emitter 40 and turn on the UVA timer circuit 200 for 6 hours. Once enabled, UVA timer circuit 200 outputs a logic high which is fed into a second logic buffer 130 and second logic inverter 140. The second logic buffer 130 controls the UVA emitter 50 to be on, while the second logic inverter 140 is used to ensure the UVC timer circuit 100 is off. Once the 6 hours is completed, the output changes state to turn off the UVA emitter 50 and turn on the UVC timer circuit 100 which turns on the UVC emitter 40 for 150 seconds, and the cycle repeats as required. The time value of each time will be determined by a variety of factors including pathogen to be eliminated, power level of UV light source, size of room, etc.
[00039] Examnle 1
[00040] UVC LED ALONE reduction Study
[00041] FLS UV Tool program was used to calculate the effect of UVC LEDS on reducing bacteria levels in an enclosed space measuring 3 metres x 3 metres x 3 metres. Nine (9) UVC LEDs each having a wavelength of 275 nm and a power rating of 244.2 mW were tested for 20% bacteria reduction and safety to human eyes and skin at various distances (floor level, 2 meters above floor level) from the light source on the ceiling (3 metres from the floor) of the enclosed space.
[00042] Each UVC LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVC LEDs and each UVC LED having a radiating angle of light source of 135° (FWHM*).
[00043] *The LED beam angle, or LED viewing angle as it is also commonly referred, measures the usable light emitted from an LED source. In most common situations, one of two methods is used to define the beam angle; the first looks for the angle at which 50% of the peak intensity is readied on either side of the origin. The second looks for the angle at which 10% of the peak intensity is reached on each side of the origin. Most commonly used is the Full Width, Half Maximum (FWHM) relating to 50% intensity, if for example an LED was measured to have 50% intensity at 15° it’s viewing angle (FWHM) would be 30°.
[00044] The following pathogens were tested with the amount of time required for the UVC to be on for 20% reduction in levels at floor level (i.e. 3 metres from light source) based on the above parameters:
Figure imgf000008_0001
Bacillus magaterium sp. (spores) 1m 1s
Bacillus magaterium sp. (veg.) 29.41s
Bacillus paratyphusus 1m 11s
Bacillus subtilis spores 4m 18s
Bacillus subtilis 2m 9s
Clostridium difficile 4m 18s
Corynebacterium diphtheriae 1m 16s
Ebertelia typhosa 48.23s
Escherichia coli 1m 17s
Leptospiracanicola - infectious Jaundice 1m 10s
Microccocus candidus 2m 24s
Microccocus sphaeroides 3m 1s
Mycobacterium tuberculosis 1m 57s
Neisseria catarrhalis 1m 39s
Phytomonas tumefaciens 1m 34s
Proteus vulgaris 1m 17s
Pseudomonas aeruginosa 2m 3s
Pseudomonas fluorescens 1m 17s
Salmonella enteritidis 1m 29s
Salmonela paratyphi - Enteric fever 1m 11s
Salmonella typhosa - Typhoid fever 48.23s
Salmonella typhimurium 2m 58s
Sarcina lutea 5m 10s
Serratia marcescens 1m 12s
Shigella dyseteriae - Dysentery 49.41s
Shigella flexneri - Dysentery 39.99s
Shigella paradysenteriae 39.99s
Spirillum rubrum 1m 12s
Staphylococcus albus 1m 7s
Staphylococcus aureus 1m 17s
Staphylococcus hemolyticus 1m 4s
Staphylococcus lactis 1m 43s
Streptococcus viridans 44.70s
Virus
Bacteriopfage - E. Coli 1m 17s
Infectious Hepatitis 1m 34s
Influenza 1m 17s
Poliovirus - Poliomyelitis 1m 17s
Yeast
Brewers yeast 1m 17s
Candida albicans 2m 29s
Common yeast cake 2m 35s
Saccharomyces carevisiae 2m 35s Saccharomyces ellipsoideus 2m 35s
Saccharomyces spores 3m 27s
[00045] UVC alone required 9 minutes and 3 seconds to reduce all bacteria by 20%. [00046] Human safety levels maximum exposure time were also measured at 1 metre from light source for wavelengths that include the UVC LED wavelength studied.
[00047]
Maximum
Wavelength
Time
180-400nm 3m 31s
300-700nm No Limit
300-700nm No Limit
180-280nm 3m 26s
280-302nm 34m 15s
303nm >8h
304nm >8h
305nm >8h
[00048] The UVC LED ONLY study shows for reduction of the bacteria levels by 20% requires 9 mins and 3 secs which would exceed the maximum safe time of 3 minutes and 26 secs above.
[00049] Example 2
[00050] UVA LED ONLY reduction study
[00051] Nine (9) UVA LEDs each having a wavelength of 405 nm and a power rating of 1000 mW were tested for reducing bacteria growth at levels safe to human eyes and skin at various distances (floor level, 1 meter above floor level, 2 meters above floor level) from the light source in a test room size of 3 metres by 3 metres by 3 metres for a duration of 40 hours.
[00052] Each UVA LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVA LEDs and each UVA LED having a radiating angle of light source of 120° (full width half max).
[00053] The pathogens of study 1 were used for this study as well. [00054] Pathogens were inhibited as follows using the UV A LED described above:
%
Reduction at system 20.00% dosage reduction time required
Bacteria
Bacillus anthracis - Anthrax 69.40% 7h 35m 46s
Bacillus anthracis spores - Anthrax spores 19.99% >24h
Bacillus magaterium sp. (spores) 86.21% 4h 32m 24s
Bacillus magaterium sp. (veg.) 98.38% 2h 10m 58s
Bacillus paratyphusus 81.53% 5h 19m 33s
Bacillus subtilis spores 37.39% 19h 12m 31s
Bacillus subtilis 60.80% 9h 36m 15s
Clostridium difficile 37.39% 19h 12m 31s
Corynebacterium diphtheriae 79.46% 5h 41m 2s
Ebertelia typhosa 91.90% 3h 34m 47s
Escherichia coli 79.01% 5h 45m 45s
Leptospiracanicola - infectious Jaundice 82.04% 5h 14m 19s
Microccocus candidus 56.73% 10h 44m 21s
Microccocus sphaeroides 48.78% 13h 26m 45s
Mycobacterium tuberculosis 64.31% 8h 43m 52s
Neisseria catarrhalis 70.24% 7h 25m 17s
Phytomonas tumetaciens 72.41% 6h 59m 5s
Proteus vulgaris 94.84% 3h 2m 6s
Pseudomonas aeruginosa 87.93% 4h 15m 18s
Pseudomonas fluorescens 79.01% 5h 45m 45s
Salmonella enteritidis 74.22% 6h 38m 8s
Salmonela paratyphi - Enteric fever 81.53% 5h 19m 33s
Salmonella typhosa - Typhoid fever 91.90% 3h 34m 47s
Salmonella typhimurium 49.23% 13h 16m 17s
Sarcina lutea 32.31% 23h 3m 1s
Serratia marcescens 81.22% 5h 22m 42s
Shigella dyseteriae - Dysentery 91.40% 3h 40m 1s
Shigella flexneri - Dysentery 95.17% 2h 58m 6s
Shigella paradysenteriae 95.17% 2h 58m 6s
Spirillum rubrum 81.22% 5h 22m 42s
Staphylococcus albus 83.49% 4h 59m 39s
Staphylococcus aureus 100.00% 42m 50s
Staphylococcus hemolyticus 84.64% 4h 48m 7s
Staphylococcus lactis 68.99% 7h 41m Os
Streptococcus viridans 93.35% 3h 19m 4s
Vibrio comma - Cholera 79.51% 5h 40m 31s [00055] The amount of time required to reduce by 20% is at least 23 hours.
[00056] Safety level were measured at 1 metre from light source.
Figure imgf000012_0001
[00057] UVA alone for reduction exceeds safety limits at 7 min and 45 secs.
[00058] Examnle 3
[00059] UVC pulse study
[00060] FLS UV tool software program was used to calculate the effect of UVC LEDS in a pulsing fashion (on for a period of time, off for a period of time) on reducing bacteria levels in an enclosed space measuring 3 metres x 3 metres x 3 metres. Nine (9) UVC LEDs each having a UVC wavelength of 275 nm and a power rating of 244.2 mW were tested for 20% bacteria reduction and safety to human eyes and skin at various distances (floor level, 2 meters above floor level) from the light source on the ceiling (3 metres from the floor) of the enclosed space.
[00061] Each UVC LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVC LEDs and each UVC LED having a radiating angle of light source of 135° (FWHM) and pulsed on for 150 sec at a time and pathogen levels were measured. Then the time required for 20% reduction was calculated based on the % reduction at 150 secs.
[00062]
Figure imgf000013_0001
Infectious Hepatitis 29.93% 1m 34s
Influenza 35.02% 1m 17s
Poliovirus - Poliomyelitis 35.02% 1m 17s
Yeast
Brewers yeast 35.02% 1m 17s
Candida albicans 20.05% 2m 29s
Common yeast cake 19.39% 2m 35s
Saccharomyces carevisiae 19.39% 2m 35s
Saccharomyces ellipsoideus 19.39% 2m 35s
Saccharomyces spores 14.93% 3m 27s
[00063] Safety levels were measured at 1 metre from light source.
Figure imgf000014_0001
[00064] For the above, pulsing UVC on at 150 sec intervals would keep within the safety limits and meet the 20% reduction levels.
[00065] Example 4
[00066] UVA for growth inhibition after UVC pulsing
[00067] FLS UV tool software program was used to calculate the effect of UVA LEDS in a pulsing fashion (on for a period of time, off for a period of time) on inhibiting bacteria levels in an enclosed space measuring 3 metres x 3 metres x 3 metres after exposure to UVC as per example 3 above. Nine (9) UVC LEDs each having a UVA wavelength of 405 nm and a power rating of 20 mW were tested for growth inhibition and safety to human eyes and skin at various distances (floor level, 2 meters above floor level) from the light source on the ceiling (3 metres from the floor) of the enclosed space.
[00068] Each UVA LED was placed on the ceiling of the room in an equidistant manner from each other resulting in a 3x3 array of UVA LEDs and each UVA LED having a radiating angle of light source of 120° (FWHM) and pulsed on for 6 hours at a time (alternating with UVC pulsing) and pathogen levels were measured.
Bacteria Pathogen Level
Bacillus anthracis - Anthrax 0.35%
Bacillus anthracis spores - Anthrax spores 0.07%
Bacillus magaterium sp. (spores) 0.59%
Bacillus magaterium sp. (veg.) 1.22%
Bacillus paratyphusus 0.50%
Bacillus subtilis spores 0.14%
Bacillus subtilis 0.28%
Clostridium difficile 0.14%
Corynebacterium diphtheriae 0.47%
Ebertelia typhosa 0.75%
Escherichia coll 0.46%
Leptospiracanicola - infectious Jaundice 0.51%
Microccocus candidus 0.25%
Microccocus sphaeroides 0.20%
Mycobacterium tuberculosis 0.31%
Neisseria catarrhalis 0.36%
Phytomonas tumefaciens 0.38%
Proteus vulgaris 0.88%
Pseudomonas aeruginosa 0.63%
Pseudomonas fluorescens 0.46%
Salmonella enteritidis 0.40%
Salmonela paratyphi - Enteric fever 0.50%
Salmonella typhosa - Typhoid fever 0.75%
Salmonella typhimurium 0.20%
Sarcina lutea 0.12%
Serratia marcescens 0.50%
Shigella dyseteriae - Dysentery 0.73%
Shigella flexneri - Dysentery 0.90%
Shigella paradysenteriae 0.90%
Spirillum rubrum 0.50%
Staphylococcus albus 0.53%
Staphylococcus aureus 368% Staphylococcus hemolyticus 0.56%
Staphylococcus lactis 0.35%
Streptococcus viridans 0.80%
Vibrio comma - Cholera 0.47%
Virus
Bacteriopfage - E. Coli 0.46%
Infectious Hepatitis 0.38%
Influenza 0.46%
Poliovirus - Poliomyelitis 0.46%
Yeast
Brewers yeast 0.46%
Candida albicans 0.24%
Common yeast cake 0.23%
Saccharomyces carevisiae 0.23%
Saccharomyces ellipsoideus 0.23%
Saccharomyces spores 0.17%
[00069] Growth of the above bacteria was inhibited using UVA. [00070] Safety levels at 1 metre below light source was:
Figure imgf000016_0001
[00071] Safety levels were not exceeded while maintaining growth inhibition with UVA/UVC combination.
[00072] The following table shows levels of Anthrax Spores on a surface of a 3x3x3 metre room as per the above conditions with UVC pulsing on/off and UV A pulsing on/off using the conditions of Examples 3 and 4.
% Level of Anthrax
Each pulse is Spores on 0.041677h Time in hours UVC UVA Surface
0.0 0.041667 ON OFF 100
0.041667 0.083333 OFF ON 94.03
0.041667 0.125 OFF ON 94.03
0.041667 0.166667 OFF ON 94.03
0.041667 0.208333 OFF ON 94.03
0.041667 0.25 OFF ON 94.03 0.041667 0.291667 OFF ON 94.03
0.041667 0.333333 OFF ON 94.03
0.041667 0.375 OFF ON 94.03
0.041667 0.416667 OFF ON 94.03
0.041667 0.458333 OFF ON 94.03
0.041667 0.5 OFF ON 94.03
0.041667 0.541667 OFF ON 94.03
0.041667 0.583333 OFF ON 94.03
0.041667 0.625 OFF ON 94.03
0.041667 0.666667 OFF ON 94.03
0.041667 0.708333 OFF ON 94.03
0.041667 0.75 OFF ON 94.03
0.041667 0.791667 OFF ON 94.03
0.041667 0.833333 OFF ON 94.03
0.041667 0.875 OFF ON 94.03
0.041667 0.916667 OFF ON 94.03
0.041667 0.958333 OFF ON 94.03
0.041667 1 OFF ON 94.03
0.041667 1.041667 OFF ON 94.03
0.041667 1.083333 OFF ON 94.03
0.041667 1.125 OFF ON 94.03
0.041667 1.166667 OFF ON 94.03
0.041667 1.208333 OFF ON 94.03
0.041667 1.25 OFF ON 94.03
0.041667 1.291667 OFF ON 94.03
0.041667 1.333333 OFF ON 94.03
0.041667 1.375 OFF ON 94.03
0.041667 1.416667 OFF ON 94.03
0.041667 1.458333 OFF ON 94.03
0.041667 1.5 OFF ON 94.03
0.041667 1.541667 OFF ON 94.03
0.041667 1.583333 OFF ON 94.03
0.041667 1.625 OFF ON 94.03
0.041667 1.666667 OFF ON 94.03
0.041667 1.708333 OFF ON 94.03
0.041667 1.75 OFF ON 94.03
0.041667 1.791667 OFF ON 94.03
0.041667 1.833333 OFF ON 94.03
0.041667 1.875 OFF ON 94.03
0.041667 1.916667 OFF ON 94.03
0.041667 1.958333 OFF ON 94.03
0.041667 2 OFF ON 94.03
0.041667 2.041667 OFF ON 94.03
0.041667 2.083333 OFF ON 94.03
0.041667 2.125 OFF ON 94.03
0.041667 2.166667 OFF ON 94.03
0041667 2208333 OFF ON 9403 0.041667 2.25 OFF ON 94.03
0.041667 2.291667 OFF ON 94.03
0.041667 2.333333 OFF ON 94.03
0.041667 2.375 OFF ON 94.03
0.041667 2.416667 OFF ON 94.03
0.041667 2.458333 OFF ON 94.03
0.041667 2.5 OFF ON 94.03
0.041667 2.541667 OFF ON 94.03
0.041667 2.583333 OFF ON 94.03
0.041667 2.625 OFF ON 94.03
0.041667 2.666667 OFF ON 94.03
0.041667 2.708333 OFF ON 94.03
0.041667 2.75 OFF ON 94.03
0.041667 2.791667 OFF ON 94.03
0.041667 2.833333 OFF ON 94.03
0.041667 2.875 OFF ON 94.03
0.041667 2.916667 OFF ON 94.03
0.041667 2.958333 OFF ON 94.03
0.041667 3 OFF ON 94.03
0.041667 3.041667 OFF ON 94.03
0.041667 3.083333 OFF ON 94.03
0.041667 3.125 OFF ON 94.03
0.041667 3.166667 OFF ON 94.03
0.041667 3.208333 OFF ON 94.03
0.041667 3.25 OFF ON 94.03
0.041667 3.291667 OFF ON 94.03
0.041667 3.333333 OFF ON 94.03
0.041667 3.375 OFF ON 94.03
0.041667 3.416667 OFF ON 94.03
0.041667 3.458333 OFF ON 94.03
0.041667 3.5 OFF ON 94.03
0.041667 3.541667 OFF ON 94.03
0.041667 3.583333 OFF ON 94.03
0.041667 3.625 OFF ON 94.03
0.041667 3.666667 OFF ON 94.03
0.041667 3.708333 OFF ON 94.03
0.041667 3.75 OFF ON 94.03
0.041667 3.791667 OFF ON 94.03
0.041667 3.833333 OFF ON 94.03
0.041667 3.875 OFF ON 94.03
0.041667 3.916667 OFF ON 94.03
0.041667 3.958333 OFF ON 94.03
0.041667 4 OFF ON 94.03
0.041667 4.041667 OFF ON 94.03
0.041667 4.083333 OFF ON 94.03
0.041667 4.125 OFF ON 94.03
0041667 4 166667 OFF ON 9403 0.041667 4.208333 OFF ON 94.03
0.041667 4.25 OFF ON 94.03
0.041667 4.291667 OFF ON 94.03
0.041667 4.333333 OFF ON 94.03
0.041667 4.375 OFF ON 94.03
0.041667 4.416667 OFF ON 94.03
0.041667 4.458333 OFF ON 94.03
0.041667 4.5 OFF ON 94.03
0.041667 4.541667 OFF ON 94.03
0.041667 4.583333 OFF ON 94.03
0.041667 4.625 OFF ON 94.03
0.041667 4.666667 OFF ON 94.03
0.041667 4.708333 OFF ON 94.03
0.041667 4.75 OFF ON 94.03
0.041667 4.791667 OFF ON 94.03
0.041667 4.833333 OFF ON 94.03
0.041667 4.875 OFF ON 94.03
0.041667 4.916667 OFF ON 94.03
0.041667 4.958333 OFF ON 94.03
0.041667 5 OFF ON 94.03
0.041667 5.041667 OFF ON 94.03
0.041667 5.083333 OFF ON 94.03
0.041667 5.125 OFF ON 94.03
0.041667 5.166667 OFF ON 94.03
0.041667 5.208333 OFF ON 94.03
0.041667 5.25 OFF ON 94.03
0.041667 5.291667 OFF ON 94.03
0.041667 5.333333 OFF ON 94.03
0.041667 5.375 OFF ON 94.03
0.041667 5.416667 OFF ON 94.03
0.041667 5.458333 OFF ON 94.03
0.041667 5.5 OFF ON 94.03
0.041667 5.541667 OFF ON 94.03
0.041667 5.583333 OFF ON 94.03
0.041667 5.625 OFF ON 94.03
0.041667 5.666667 OFF ON 94.03
0.041667 5.708333 OFF ON 94.03
0.041667 5.75 OFF ON 94.03
0.041667 5.791667 OFF ON 94.03
0.041667 5.833333 OFF ON 94.03
0.041667 5.875 OFF ON 94.03
0.041667 5.916667 OFF ON 94.03
0.041667 5.958333 OFF ON 94.03
0.041667 6 OFF ON 94.03
0.041667 6.041667 ON OFF 88.41641
0.041667 6.083333 OFF ON 88.41641
0041667 6 125 OFF ON 8841641 0.041667 6.166667 OFF ON 88.41641
0.041667 6.208333 OFF ON 88.41641
0.041667 6.25 OFF ON 88.41641
0.041667 6.291667 OFF ON 88.41641
0.041667 6.333333 OFF ON 88.41641
0.041667 6.375 OFF ON 88.41641
0.041667 6.416667 OFF ON 88.41641
0.041667 6.458333 OFF ON 88.41641
0.041667 6.5 OFF ON 88.41641
0.041667 6.541667 OFF ON 88.41641
0.041667 6.583333 OFF ON 88.41641
0.041667 6.625 OFF ON 88.41641
0.041667 6.666667 OFF ON 88.41641
0.041667 6.708333 OFF ON 88.41641
0.041667 6.75 OFF ON 88.41641
0.041667 6.791667 OFF ON 88.41641
0.041667 6.833333 OFF ON 88.41641
0.041667 6.875 OFF ON 88.41641
0.041667 6.916667 OFF ON 88.41641
0.041667 6.958333 OFF ON 88.41641
0.041667 7 OFF ON 88.41641
0.041667 7.041667 OFF ON 88.41641
0.041667 7.083333 OFF ON 88.41641
0.041667 7.125 OFF ON 88.41641
0.041667 7.166667 OFF ON 88.41641
0.041667 7.208333 OFF ON 88.41641
0.041667 7.25 OFF ON 88.41641
0.041667 7.291667 OFF ON 88.41641
0.041667 7.333333 OFF ON 88.41641
0.041667 7.375 OFF ON 88.41641
0.041667 7.416667 OFF ON 88.41641
0.041667 7.458333 OFF ON 88.41641
0.041667 7.5 OFF ON 88.41641
0.041667 7.541667 OFF ON 88.41641
0.041667 7.583333 OFF ON 88.41641
0.041667 7.625 OFF ON 88.41641
0.041667 7.666667 OFF ON 88.41641
0.041667 7.708333 OFF ON 88.41641
0.041667 7.75 OFF ON 88.41641
0.041667 7.791667 OFF ON 88.41641
0.041667 7.833333 OFF ON 88.41641
0.041667 7.875 OFF ON 88.41641
0.041667 7.916667 OFF ON 88.41641
0.041667 7.958333 OFF ON 88.41641
0.041667 8 OFF ON 88.41641
0.041667 8.041667 OFF ON 88.41641
0041667 8083333 OFF ON 8841641 0.041667 8.125 OFF ON 88.41641
0.041667 8.166667 OFF ON 88.41641
0.041667 8.208333 OFF ON 88.41641
0.041667 8.25 OFF ON 88.41641
0.041667 8.291667 OFF ON 88.41641
0.041667 8.333333 OFF ON 88.41641
0.041667 8.375 OFF ON 88.41641
0.041667 8.416667 OFF ON 88.41641
0.041667 8.458333 OFF ON 88.41641
0.041667 8.5 OFF ON 88.41641
0.041667 8.541667 OFF ON 88.41641
0.041667 8.583333 OFF ON 88.41641
0.041667 8.625 OFF ON 88.41641
0.041667 8.666667 OFF ON 88.41641
0.041667 8.708333 OFF ON 88.41641
0.041667 8.75 OFF ON 88.41641
0.041667 8.791667 OFF ON 88.41641
0.041667 8.833333 OFF ON 88.41641
0.041667 8.875 OFF ON 88.41641
0.041667 8.916667 OFF ON 88.41641
0.041667 8.958333 OFF ON 88.41641
0.041667 9 OFF ON 88.41641
0.041667 9.041667 OFF ON 88.41641
0.041667 9.083333 OFF ON 88.41641
0.041667 9.125 OFF ON 88.41641
0.041667 9.166667 OFF ON 88.41641
0.041667 9.208333 OFF ON 88.41641
0.041667 9.25 OFF ON 88.41641
0.041667 9.291667 OFF ON 88.41641
0.041667 9.333333 OFF ON 88.41641
0.041667 9.375 OFF ON 88.41641
0.041667 9.416667 OFF ON 88.41641
0.041667 9.458333 OFF ON 88.41641
0.041667 9.5 OFF ON 88.41641
0.041667 9.541667 OFF ON 88.41641
0.041667 9.583333 OFF ON 88.41641
0.041667 9.625 OFF ON 88.41641
0.041667 9.666667 OFF ON 88.41641
0.041667 9.708333 OFF ON 88.41641
0.041667 9.75 OFF ON 88.41641
0.041667 9.791667 OFF ON 88.41641
0.041667 9.833333 OFF ON 88.41641
0.041667 9.875 OFF ON 88.41641
0.041667 9.916667 OFF ON 88.41641
0.041667 9.958333 OFF ON 88.41641
0.041667 10 OFF ON 88.41641
0.041667 10.04167 OFF ON 88.41641 0.041667 10.08333 OFF ON 88.41641
0.041667 10.125 OFF ON 88.41641
0.041667 10.16667 OFF ON 88.41641
0.041667 10.20833 OFF ON 88.41641
0.041667 10.25 OFF ON 88.41641
0.041667 10.29167 OFF ON 88.41641
0.041667 10.33333 OFF ON 88.41641
0.041667 10.375 OFF ON 88.41641
0.041667 10.41667 OFF ON 88.41641
0.041667 10.45833 OFF ON 88.41641
0.041667 10.5 OFF ON 88.41641
0.041667 10.54167 OFF ON 88.41641
0.041667 10.58333 OFF ON 88.41641
0.041667 10.625 OFF ON 88.41641
0.041667 10.66667 OFF ON 88.41641
0.041667 10.70833 OFF ON 88.41641
0.041667 10.75 OFF ON 88.41641
0.041667 10.79167 OFF ON 88.41641
0.041667 10.83333 OFF ON 88.41641
0.041667 10.875 OFF ON 88.41641
0.041667 10.91667 OFF ON 88.41641
0.041667 10.95833 OFF ON 88.41641
0.041667 11 OFF ON 88.41641
0.041667 11.04167 OFF ON 88.41641
0.041667 11.08333 OFF ON 88.41641
0.041667 11.125 OFF ON 88.41641
0.041667 11.16667 OFF ON 88.41641
0.041667 11.20833 OFF ON 88.41641
0.041667 11.25 OFF ON 88.41641
0.041667 11.29167 OFF ON 88.41641
0.041667 11.33333 OFF ON 88.41641
0.041667 11.375 OFF ON 88.41641
0.041667 11.41667 OFF ON 88.41641
0.041667 11.45833 OFF ON 88.41641
0.041667 11.5 OFF ON 88.41641
0.041667 11.54167 OFF ON 88.41641
0.041667 11.58333 OFF ON 88.41641
0.041667 11.625 OFF ON 88.41641
0.041667 11.66667 OFF ON 88.41641
0.041667 11.70833 OFF ON 88.41641
0.041667 11.75 OFF ON 88.41641
0.041667 11.79167 OFF ON 88.41641
0.041667 11.83333 OFF ON 88.41641
0.041667 11.875 OFF ON 88.41641
0.041667 11.91667 OFF ON 88.41641
0.041667 11.95833 OFF ON 88.41641
0.041667 12 OFF ON 88.41641 0.041667 12.04167 ON OFF 83.13795
0.041667 12.08333 OFF ON 83.13795
0.041667 12.125 OFF ON 83.13795
0.041667 12.16667 OFF ON 83.13795
0.041667 12.20833 OFF ON 83.13795
0.041667 12.25 OFF ON 83.13795
0.041667 12.29167 OFF ON 83.13795
0.041667 12.33333 OFF ON 83.13795
0.041667 12.375 OFF ON 83.13795
0.041667 12.41667 OFF ON 83.13795
0.041667 12.45833 OFF ON 83.13795
0.041667 12.5 OFF ON 83.13795
0.041667 12.54167 OFF ON 83.13795
0.041667 12.58333 OFF ON 83.13795
0.041667 12.625 OFF ON 83.13795
0.041667 12.66667 OFF ON 83.13795
0.041667 12.70833 OFF ON 83.13795
0.041667 12.75 OFF ON 83.13795
0.041667 12.79167 OFF ON 83.13795
0.041667 12.83333 OFF ON 83.13795
0.041667 12.875 OFF ON 83.13795
0.041667 12.91667 OFF ON 83.13795
0.041667 12.95833 OFF ON 83.13795
0.041667 13 OFF ON 83.13795
0.041667 13.04167 OFF ON 83.13795
0.041667 13.08333 OFF ON 83.13795
0.041667 13.125 OFF ON 83.13795
0.041667 13.16667 OFF ON 83.13795
0.041667 13.20833 OFF ON 83.13795
0.041667 13.25 OFF ON 83.13795
0.041667 13.29167 OFF ON 83.13795
0.041667 13.33333 OFF ON 83.13795
0.041667 13.375 OFF ON 83.13795
0.041667 13.41667 OFF ON 83.13795
0.041667 13.45833 OFF ON 83.13795
0.041667 13.5 OFF ON 83.13795
0.041667 13.54167 OFF ON 83.13795
0.041667 13.58333 OFF ON 83.13795
0.041667 13.625 OFF ON 83.13795
0.041667 13.66667 OFF ON 83.13795
0.041667 13.70833 OFF ON 83.13795
0.041667 13.75 OFF ON 83.13795
0.041667 13.79167 OFF ON 83.13795
0.041667 13.83333 OFF ON 83.13795
0.041667 13.875 OFF ON 83.13795
0.041667 13.91667 OFF ON 83.13795
0.041667 13.95833 OFF ON 83.13795 0.041667 14 OFF ON 83.13795
0.041667 14.04167 OFF ON 83.13795
0.041667 14.08333 OFF ON 83.13795
0.041667 14.125 OFF ON 83.13795
0.041667 14.16667 OFF ON 83.13795
0.041667 14.20833 OFF ON 83.13795
0.041667 14.25 OFF ON 83.13795
0.041667 14.29167 OFF ON 83.13795
0.041667 14.33333 OFF ON 83.13795
0.041667 14.375 OFF ON 83.13795
0.041667 14.41667 OFF ON 83.13795
0.041667 14.45833 OFF ON 83.13795
0.041667 14.5 OFF ON 83.13795
0.041667 14.54167 OFF ON 83.13795
0.041667 14.58333 OFF ON 83.13795
0.041667 14.625 OFF ON 83.13795
0.041667 14.66667 OFF ON 83.13795
0.041667 14.70833 OFF ON 83.13795
0.041667 14.75 OFF ON 83.13795
0.041667 14.79167 OFF ON 83.13795
0.041667 14.83333 OFF ON 83.13795
0.041667 14.875 OFF ON 83.13795
0.041667 14.91667 OFF ON 83.13795
0.041667 14.95833 OFF ON 83.13795
0.041667 15 OFF ON 83.13795
0.041667 15.04167 OFF ON 83.13795
0.041667 15.08333 OFF ON 83.13795
0.041667 15.125 OFF ON 83.13795
0.041667 15.16667 OFF ON 83.13795
0.041667 15.20833 OFF ON 83.13795
0.041667 15.25 OFF ON 83.13795
0.041667 15.29167 OFF ON 83.13795
0.041667 15.33333 OFF ON 83.13795
0.041667 15.375 OFF ON 83.13795
0.041667 15.41667 OFF ON 83.13795
0.041667 15.45833 OFF ON 83.13795
0.041667 15.5 OFF ON 83.13795
0.041667 15.54167 OFF ON 83.13795
0.041667 15.58333 OFF ON 83.13795
0.041667 15.625 OFF ON 83.13795
0.041667 15.66667 OFF ON 83.13795
0.041667 15.70833 OFF ON 83.13795
0.041667 15.75 OFF ON 83.13795
0.041667 15.79167 OFF ON 83.13795
0.041667 15.83333 OFF ON 83.13795
0.041667 15.875 OFF ON 83.13795
0.041667 15.91667 OFF ON 83.13795 0.041667 15.95833 OFF ON 83.13795
0.041667 16 OFF ON 83.13795
0.041667 16.04167 OFF ON 83.13795
0.041667 16.08333 OFF ON 83.13795
0.041667 16.125 OFF ON 83.13795
0.041667 16.16667 OFF ON 83.13795
0.041667 16.20833 OFF ON 83.13795
0.041667 16.25 OFF ON 83.13795
0.041667 16.29167 OFF ON 83.13795
0.041667 16.33333 OFF ON 83.13795
0.041667 16.375 OFF ON 83.13795
0.041667 16.41667 OFF ON 83.13795
0.041667 16.45833 OFF ON 83.13795
0.041667 16.5 OFF ON 83.13795
0.041667 16.54167 OFF ON 83.13795
0.041667 16.58333 OFF ON 83.13795
0.041667 16.625 OFF ON 83.13795
0.041667 16.66667 OFF ON 83.13795
0.041667 16.70833 OFF ON 83.13795
0.041667 16.75 OFF ON 83.13795
0.041667 16.79167 OFF ON 83.13795
0.041667 16.83333 OFF ON 83.13795
0.041667 16.875 OFF ON 83.13795
0.041667 16.91667 OFF ON 83.13795
0.041667 16.95833 OFF ON 83.13795
0.041667 17 OFF ON 83.13795
0.041667 17.04167 OFF ON 83.13795
0.041667 17.08333 OFF ON 83.13795
0.041667 17.125 OFF ON 83.13795
0.041667 17.16667 OFF ON 83.13795
0.041667 17.20833 OFF ON 83.13795
0.041667 17.25 OFF ON 83.13795
0.041667 17.29167 OFF ON 83.13795
0.041667 17.33333 OFF ON 83.13795
0.041667 17.375 OFF ON 83.13795
0.041667 17.41667 OFF ON 83.13795
0.041667 17.45833 OFF ON 83.13795
0.041667 17.5 OFF ON 83.13795
0.041667 17.54167 OFF ON 83.13795
0.041667 17.58333 OFF ON 83.13795
0.041667 17.625 OFF ON 83.13795
0.041667 17.66667 OFF ON 83.13795
0.041667 17.70833 OFF ON 83.13795
0.041667 17.75 OFF ON 83.13795
0.041667 17.79167 OFF ON 83.13795
0.041667 17.83333 OFF ON 83.13795
0.041667 17.875 OFF ON 83.13795 0.041667 17.91667 OFF ON 83.13795
0.041667 17.95833 OFF ON 83.13795
0.041667 18 OFF ON 83.13795
0.041667 18.04167 ON OFF 78.17461
0.041667 18.08333 OFF ON 78.17461
0.041667 18.125 OFF ON 78.17461
0.041667 18.16667 OFF ON 78.17461
0.041667 18.20833 OFF ON 78.17461
0.041667 18.25 OFF ON 78.17461
0.041667 18.29167 OFF ON 78.17461
0.041667 18.33333 OFF ON 78.17461
0.041667 18.375 OFF ON 78.17461
0.041667 18.41667 OFF ON 78.17461
0.041667 18.45833 OFF ON 78.17461
0.041667 18.5 OFF ON 78.17461
0.041667 18.54167 OFF ON 78.17461
0.041667 18.58333 OFF ON 78.17461
0.041667 18.625 OFF ON 78.17461
0.041667 18.66667 OFF ON 78.17461
0.041667 18.70833 OFF ON 78.17461
0.041667 18.75 OFF ON 78.17461
0.041667 18.79167 OFF ON 78.17461
0.041667 18.83333 OFF ON 78.17461
0.041667 18.875 OFF ON 78.17461
0.041667 18.91667 OFF ON 78.17461
0.041667 18.95833 OFF ON 78.17461
0.041667 19 OFF ON 78.17461
0.041667 19.04167 OFF ON 78.17461
0.041667 19.08333 OFF ON 78.17461
0.041667 19.125 OFF ON 78.17461
0.041667 19.16667 OFF ON 78.17461
0.041667 19.20833 OFF ON 78.17461
0.041667 19.25 OFF ON 78.17461
0.041667 19.29167 OFF ON 78.17461
0.041667 19.33333 OFF ON 78.17461
0.041667 19.375 OFF ON 78.17461
0.041667 19.41667 OFF ON 78.17461
0.041667 19.45833 OFF ON 78.17461
0.041667 19.5 OFF ON 78.17461
0.041667 19.54167 OFF ON 78.17461
0.041667 19.58333 OFF ON 78.17461
0.041667 19.625 OFF ON 78.17461
0.041667 19.66667 OFF ON 78.17461
0.041667 19.70833 OFF ON 78.17461
0.041667 19.75 OFF ON 78.17461
0.041667 19.79167 OFF ON 78.17461
0.041667 19.83333 OFF ON 78.17461 0.041667 19.875 OFF ON 78.17461
0.041667 19.91667 OFF ON 78.17461
0.041667 19.95833 OFF ON 78.17461
0.041667 20 OFF ON 78.17461
0.041667 20.04167 OFF ON 78.17461
0.041667 20.08333 OFF ON 78.17461
0.041667 20.125 OFF ON 78.17461
0.041667 20.16667 OFF ON 78.17461
0.041667 20.20833 OFF ON 78.17461
0.041667 20.25 OFF ON 78.17461
0.041667 20.29167 OFF ON 78.17461
0.041667 20.33333 OFF ON 78.17461
0.041667 20.375 OFF ON 78.17461
0.041667 20.41667 OFF ON 78.17461
0.041667 20.45833 OFF ON 78.17461
0.041667 20.5 OFF ON 78.17461
0.041667 20.54167 OFF ON 78.17461
0.041667 20.58333 OFF ON 78.17461
0.041667 20.625 OFF ON 78.17461
0.041667 20.66667 OFF ON 78.17461
0.041667 20.70833 OFF ON 78.17461
0.041667 20.75 OFF ON 78.17461
0.041667 20.79167 OFF ON 78.17461
0.041667 20.83333 OFF ON 78.17461
0.041667 20.875 OFF ON 78.17461
0.041667 20.91667 OFF ON 78.17461
0.041667 20.95833 OFF ON 78.17461
0.041667 21 OFF ON 78.17461
0.041667 21.04167 OFF ON 78.17461
0.041667 21.08333 OFF ON 78.17461
0.041667 21.125 OFF ON 78.17461
0.041667 21.16667 OFF ON 78.17461
0.041667 21.20833 OFF ON 78.17461
0.041667 21.25 OFF ON 78.17461
0.041667 21.29167 OFF ON 78.17461
0.041667 21.33333 OFF ON 78.17461
0.041667 21.375 OFF ON 78.17461
0.041667 21.41667 OFF ON 78.17461
0.041667 21.45833 OFF ON 78.17461
0.041667 21.5 OFF ON 78.17461
0.041667 21.54167 OFF ON 78.17461
0.041667 21.58333 OFF ON 78.17461
0.041667 21.625 OFF ON 78.17461
0.041667 21.66667 OFF ON 78.17461
0.041667 21.70833 OFF ON 78.17461
0.041667 21.75 OFF ON 78.17461
0.041667 21.79167 OFF ON 78.17461 0.041667 21.83333 OFF ON 78.17461
0.041667 21.875 OFF ON 78.17461
0.041667 21.91667 OFF ON 78.17461
0.041667 21.95833 OFF ON 78.17461
0.041667 22 OFF ON 78.17461
0.041667 22.04167 OFF ON 78.17461
0.041667 22.08333 OFF ON 78.17461
0.041667 22.125 OFF ON 78.17461
0.041667 22.16667 OFF ON 78.17461
0.041667 22.20833 OFF ON 78.17461
0.041667 22.25 OFF ON 78.17461
0.041667 22.29167 OFF ON 78.17461
0.041667 22.33333 OFF ON 78.17461
0.041667 22.375 OFF ON 78.17461
0.041667 22.41667 OFF ON 78.17461
0.041667 22.45833 OFF ON 78.17461
0.041667 22.5 OFF ON 78.17461
0.041667 22.54167 OFF ON 78.17461
0.041667 22.58333 OFF ON 78.17461
0.041667 22.625 OFF ON 78.17461
0.041667 22.66667 OFF ON 78.17461
0.041667 22.70833 OFF ON 78.17461
0.041667 22.75 OFF ON 78.17461
0.041667 22.79167 OFF ON 78.17461
0.041667 22.83333 OFF ON 78.17461
0.041667 22.875 OFF ON 78.17461
0.041667 22.91667 OFF ON 78.17461
0.041667 22.95833 OFF ON 78.17461
0.041667 23 OFF ON 78.17461
0.041667 23.04167 OFF ON 78.17461
0.041667 23.08333 OFF ON 78.17461
0.041667 23.125 OFF ON 78.17461
0.041667 23.16667 OFF ON 78.17461
0.041667 23.20833 OFF ON 78.17461
0.041667 23.25 OFF ON 78.17461
0.041667 23.29167 OFF ON 78.17461
0.041667 23.33333 OFF ON 78.17461
0.041667 23.375 OFF ON 78.17461
0.041667 23.41667 OFF ON 78.17461
0.041667 23.45833 OFF ON 78.17461
0.041667 23.5 OFF ON 78.17461
0.041667 23.54167 OFF ON 78.17461
0.041667 23.58333 OFF ON 78.17461
0.041667 23.625 OFF ON 78.17461
0.041667 23.66667 OFF ON 78.17461
0.041667 23.70833 OFF ON 78.17461
0.041667 23.75 OFF ON 78.17461
Figure imgf000029_0002
[00073] As may be seen from the above, when the UVC is pulsed on, the bacteria is killed to a certain level and UVC is pulsed off with UVA pulsed on keeping the bacteria level the same without any growth. The UVA is then pulsed off and UVC is pulsed on with further bacteria kill and subsequent UVA on after UVC is off maintains the new lower level of bacteria on the surface (i.e. further growth inhibition. The ON/OFF pulsing method reduces the level of bacteria on the surface by about 20% between 12-18 hours and inhibits bacteria growth for at least 24 hours while keeping radiation levels safe for humans.
[00074] Example 5
[00075] UVA/UVC pulsing compared to no UV on E.
Figure imgf000029_0001
[00076] Abbreviations
[00077] ATP; Adenosine triphosphate, CFU; Colony forming unit, RLU; Relative luminescence units, SEM; Standard error of the mean, TNTC; Too numerous to count, UVA; Ultraviolet A, UVC; Ultraviolet C.
[00078] Materials
[00079] Nutrient agar, maximum recovery diluent, violet red bile glucose agar and tryptone soya broth was purchased from Oxoid Ltd (Basingstoke, Hampshire UK). Petri dishes were purchased from Scientific Lab Supplies Ltd UK. UltraSnap1 M Adenosine triphosphate (ATP) surface tests were purchased from Hygiena International Ltd. E. Coli K12 was purchased from Blades Biological Ltd (East Sussex, UK).
[00080] Equipment
Figure imgf000029_0003
[00081] Scheme of equipment set up (not to scale). The two buttons on the control box represent the UV A and UVC switches. The lamp was placed 32cm away from the petti dish.
[00082] The equipment was housed in a Syngene Bioimaging light box for protection of exposure to UVA and UVC. The wire from the lamp was wrapped around the clamp stand in order to ensure that the lamp was frilly exposing the petri dish. The lamp was placed 32cm away from the petti dish. The lamp and control box were provided by Helios. The autoclave was an Eclipse 17 and a Genlab incubator was used for organism growth. The temperature of the box was maintained at room temperature. A Hygiena luminometer was used for ATP readings.
[00083] Experimental
[00084] Micro-organism and culture methods
[00085] Test organism was E. Coli K12. Agar was sterilised at 121°C. The organism was grown in tryptone soya broth and incubated for 12 hours at 37°C. E. Coli K12 was validated using violet red bile glucose agar. Maximal recovery diluent was autoclaved prior to use. E. Coli K12 was diluted to 1 in 10,000 in maximal recovery diluent in order to be counted using a lawn plate approach. 10μL of E. Coli K12 was pipetted in four different areas on the nutrient three agar plate in sterile conditions. The plates were then stored in one of three conditions: dark, natural light and UV light. The details regarding the UV light exposure are recorded in Protocol I and Protocol II. After exposure, plates were incubated for 24 hours at 37°C and colonies were counted.
[00086] Protocol I
[00087] Non-Treated plates were exposed to natural light and dark conditions.
[00088] Protocol Π
[00089] UVA, nominal wavelength of 405nm, was set to a power intensity of 42mW, and UVC nominal wavelength of 275nm, was set to a power intensity of 117mW. UVC was engaged with UVA extinguished for 3 minutes and UVA engaged for 30 minutes with UVC extinguished. This was completed for a total of 10-13 cycles with a total exposure time between 330 minutes and 429 minutes, respectively.
[00090] ATP Measurement
[00091] ATP measurements were conducted in instances where no visible colonies were present. The UltraSnap™ swabs were equilibrated at room temperature. The surface of the petri dish was swabbed thoroughly. The swab was replaced back into the tube and the tube was placed into the Hygiena luminometer within 30 seconds and ATP levels were recorded. Readings less than 10 relative luminescence units (RLU) are considered clean. Readings between 11-29 RLU indicate a warning and readings above 30 RLU indicate a dirty surface.
[00092] CFU Assessment
[00093] Colony forming units (CFUs) are counted based on the number of viable bacterial cells. This is undertaken with the aid of a microscope. The number of bacteria per mL of sample is calculated by dividing the colony number by the dilution factor employed. This is a direct count method.
[00094] Results
[00095] The survival of the E. Coli K12 was monitored over different time periods.
[00096] Protocol I
[00097] The bacterial growth present were too numerous to count (TNTC) on the dark and natural light plates hence it was not possible to determine the number of colony forming units (CFU). In order to assess the surface, ATP measurements were performed.
Time ATP (RLU)
Dark Natural Light
12 5389 7496 hours
[00098] Table 1 : Measurements of ATP in RLU in dark and natural light conditions
[00099] The differences in levels of dark and natural light bacteria are due to within day variations as there will be a small difference in temperature and amount of light exposed.
[000100] Protocol Π
[000101] Following 3 repetitions of 13 iterations of Protocol Π described above, we observed a 32±3% (average ± standard error of the mean (SEM)) reduction in CFU on comparison of the UV exposed bacteria in comparison to the bacteria stored in natural light. These values may change considering different distances and different intensity and time periods for pulsing.
Repeat Average / lOul Standard Average %
Deviation CFU / 1ml Difference
1 11.5 1.12 1150 28.26
2 8.5 2.22 850 33.33
3 4.9 1.88 486 35.29 Average % SD % SEM %
Difference Difference Difference
32.296 2.964 2.095
[000102] Table 2. Summary of effects from UV Protocol II on bacterial load for 13 cycles
[000103] Following 10 cycles of the protocol described above we observed a 6% reduction in bacterial load, on comparison of the bacteria exposed to UV light compared to the dark. This shows that differences are observed with less exposure time to the UV light using this pulse sequence.
Condition Average % SD % SEM %
Comparison Difference Difference Difference
UV/Daik 35.0 12.3 8.7 UV/Natural Light 32.3 3.0 2.1
[000104] Table 3. Comparisons of conditions (natural light vs dark) on data from 13 cycles.
[000105] A 32±3% reduction in bacterial load across a 13 iteration repeat of 33 minute irradiation cycles (Protocol Π) is shown. Additionally, Protocol II compared to controls exposed to natural light and dark elicited a 35±12% reduction in bacterial load.
[000106] Example 6
[000107] UVA/UVC pulsing on E. Coli K12, Bacillus Subtilis and Staphylococcus Epidermis
[000108] This example investigated UVA and UVC irradiation on an array of bacteria considering a variety of power settings and times, the impact of UVA and UVC pulsing on an array of bacteria considering a variety of distances and exposure times and to use modelling in order to establish cross contamination risk following exposure with UV light.
[000109] Materials
[000110] Nutrient agar, maximum recovery diluent, violet red bile glucose agar and tryptone soya broth was purchased from Oxoid Ltd (Basingstoke, Hampshire UK).
Single vent petri dishes were purchased from Scientific Lab Supplies Ltd UK. UltraSnap Adenosine triphosphate (ATP) surface tests were purchased from Hygiena International Ltd. Escherichia Coli K12, Bacillus Subtilis and Staphylococcus Epidermidis was purchased from Blades Biological Ltd (East Sussex, UK).
[000111] Equipment
Figure imgf000033_0001
[000112] Scheme of equipment set up (not to scale). Blue (outerlined) box represents the housing of the equipment in light box. The two green buttons on the control represent the UV A and UVC switches. The lamp was placed 32cm away from the petti dish.
[000113] The equipment was housed in a Syngene Bioimaging light box for protection of exposure to UVA and UVC. The wire from the lamp was wrapped around the clamp stand in order to ensure that the petti dish was fully exposed to the lamp. The lamp was placed 32cm away from the petti dish for all experiments with exception to where different distances are stated. The lamp and control were provided by Helios Shield Ltd. UVA and UVC exposure dials were utilised for direct exposure. The control stated a total of 16 different settings for the lamp. This apparatus assembly was constructed in Nottingham Trent University, UK
[000114] The autoclave (Eclipse 17) was utilised in order to sterilise all equipment and a Genlab incubator was used for organism growth which was maintained at 37°C throughout the experiment period. The temperature of the box was maintained at room temperature which fluctuated between 18°C and 25°C. A Hygiena luminometer was used for ATP readings.
[000115] This experimental design set up is similar to that described by Bolton, J. R and Linden, K G. (2003) Standardization of Methods for Fluence (UV Dosage) Determination in Bench-Scale UV Experiments. Journal of Environmental Engineering 129 (3) 209-215).
[000116] This research article outlined the importance of standardising UV experiment bench-scale experimental set up, and was one of highlighted discussion points. The only missing attribute from the experimental set up described herein is the use of a stirrer and petri dish (Bolton and Linden 2003) however, this is deemed inappropriate for the methodology due to using a lawn plate approach.
[000117] Experimental
[000118] Micro-organism and culture methods
[000119] Test organisms include E. Coli K12, B. Subtilis and S. Epider midis. Nutrient agar and violet blue red agar were prepared, as per the protocol from the manufacturer, and was sterilised at 121°C and 110.4 kPa for a 1 hour period. Both types of agar were poured into singlet vent petri dishes, left to dry and set before being stored at 4°C prior to use. Organisms (B. Subtilis and S. Epidermidis) were grown in tryptone soya broth and incubated for 12 hours at 37°C. E. Coli K12 was validated using violet red bile glucose agar using the streaking method. B. Subtilis and S. Epidermidis were validated using the Nutrient agar. Maximal recovery diluent was autoclaved prior to use. E. Coli K12, B. Subtilis and S. Epidermidis was diluted to 1 in 10,000 in maximal recovery diluent in order to be counted using a lawn plate approach. 10μL of E. Coli K12 was pipetted in different areas on the nutrient three nutrient agar plates under sterile conditions. The plates were then stored in one of three conditions: dark, natural light and UV light for different periods of time. The details regarding the UV light exposure, time of exposure and distance from the UV lamp are recorded in Protocol I and Protocol Π below. After exposure, plates were incubated for 24 hours at 37°C and colonies were counted. In the instances where the bacteria was too numerous to count (TNTC), ATP measurements were performed.
[000120] Protocol I
[000121] UVA and UVC were used simultaneously on the agar plates for a period of 12 hours using various power levels including 42mW, 117mW and 65mW. This was performed for all microorganisms in the investigation, E. Coli K12, B. Subtilis and S. Epidermidis. The bacteria were then grown for a 24 hour period and data was acquired.
[000122] Protocol Π
[000123] UVA and UVC were pulsed using power levels 42mW and 65mW, respectively. UVC was engaged for 3 minutes, then UVC was disengaged. Subsequently UVA was engaged for 30 minutes and then UVA was disengaged. This was completed for a total of 10-13 iterations with a total exposure time between 270 minutes and 399 minutes, respectively. The bacteria were then grown for a 24 hour period and data was acquired. This was performed for E. Coli K12 and S. Epidermidis strains.
[000124] ATP Measurement
[000125] ATP measurements were conducted in instances where no colonies were visible on the agar plates or bacteria colonies were TNTC. The UltraSnap ΤΜ swabs were equilibrated at room temperature (storage for UltraSnap TM swabs are at 21 °C). The surface of the petri dish was swabbed thoroughly, specifically the centre of the plate where bacteria had been pipetted directly. The swab was replaced back into the tube and the liquid-stable reagent from the UltraSnap™ swab was added. The purpose of the addition of the liquid-stable reagent is to facilitate the bioluminescence reaction and optimises sample recovery. The unique liquid-stable reagent gives superior sensitivity and reliable results, with a sensitivity stated of O.OOlfinol. The tube was placed into the Hygiena luminometer within 30 seconds and ATP levels were recorded using a new solid-state photodiode. Photodiodes have the ability to detect and quantify low levels of light. The light emitted is in direct proportion to the amount of ATP present in the sample. Readings less than 10 relative luminescence units (RLU) are considered clean. Readings between 11-29 RLU indicate a warning and readings above 30 RLU indicate a dirty surface. Food manufacturing and healthcare settings both use ATP to determine whether surfaces are clean or not.
[000126] Modelling for Cross Contamination Risks
[000127] Dose-response model have been derived in order to assess the cross- contamination risk. This modelling helps in the understanding of exposure to pathogens and is crucial in risk assessments (Haas, C. N. (2015) Microbial Dose Response Modeling: Past, Present and Future. Environment Science and Technology 49 1245-1259). An exponential distribution has been developed (Watanabe, T. et al. (2010) Development of a Dose-Response Model for SARS Coronavirus. Risk Analysis 30 7) and is classified as a Generation 1 model i.e. a model that describes the probability of response to exposed dose (Haas 2015).
Figure imgf000035_0001
[000129] Where p(d) is the risk of illness at the dose of d and k is a parameter specific for the pathogen (Watanabe et al. 2010). Parameter k is the probability that a single pathogen will initiate the response (Watanabe et al. 2010). Parameter k is developed for each microorganism (Watanabe et al. 2010). This exponential model will be applied in order to assess the cross-contamination risks. [000130] Results and Discussion
[000131] The survival of the E. Coli K12, S. Epidermis and B. Subtilis was monitored over different time periods using both Protocol I and Protocol Π.
[000132] Protocol I
[000133] The bacterial growth present were TNTC for E. Coli, S. Epidermis and B. Subtilis on the dark and natural light plates, hence it was not possible to determine the number of colony forming units (CFU). Moreover, no bacteria were visible with the naked eye for the UV light condition for all strains tested. Therefore, in order to assess the surface and any remaining bacteria present and if the surfaces were contaminated, ATP measurements were performed.
Strain Setting Setting for Time ATP (RLU) for UVA UVC (hours) Dark UV Light Natural Light
B. Subtilis 65mW 65mW 12 2431 0 3893
117mW 117mW 12 7580 4 7937
42mW 65mW 12 95 5 1062
E. ColiK12 117mW 117mW 12 7004 0 6031
65mW 65mW 12 5389 0 7496
S. Epidermis 117mW 117mW 12 7701 0 8811
65mW 65mW 12 8272 0 8899
42mW 65mW 12 8297 0 3561
[000134] Table 4: Measurements of ATP in RLU in dark, natural light and UV light conditions using different power levels for UVA and UVC, F, 42mW and 65mW, for different strains, E. Coli K12, S. Epidermis and/?. Subtilis.
[000135] These results show that the combination of UVA and UVC light at power level 42mW, 117mW and 65mW are equally as effective at killing bacteria in the combinations described above (Table 4). The differences in levels of dark and natural light bacteria are due to within day variations, as there will be a small difference in temperature and amount of natural light exposed. Conclusively, it can be demonstrated that a 12 hour period of using any of the aforementioned UVC and UVA power levels shows a nearly 100% reduction in ATP and are below the clean limit of 10 RLU. Herein, we demonstrate this using three different strains of bacteria including E Coli K12, S. Epidermis and B. Subtilis.
[000136] Protocol Π [000137] Distance Measurements
Figure imgf000037_0001
[000138] Graph 1. Distance of the lamp from the bacteria versus percentage difference (%) in bacteria loading comparing the UV light with the natural light conditions (blue) and dark conditions (grey) using E. Coli K12 as a typical model.
[000139] Following 13 iterations of the protocol described above, we observed a 32±3%
(average ± standard error of the mean (SEM)) reduction in CFU on comparison of the
UV exposed bacteria in comparison to the bacteria stored in natural light at 32cm
(graph 1). 13 iterations included a total time of 39 minutes ofUVC and 360 minutes of
UVA exposure. These values may change considering different intensities. Following
13 iterations of the protocol described above, we observed a 35±8% (average ± SEM) reduction in CFU on comparison of the UV exposed bacteria in comparison to the bacteria stored in the dark at 32cm (graph 1). These findings are using E. Coli K12 as a typical model organism utilising n = 36 readings. Similar findings were observed considering S. Epidermis which, using the same aforementioned power levels revealed a 36±2% (average ± SEM) reduction in CFU on comparison to UV exposed bacteria compared to bacteria stored in the dark at 32cm Similar findings were observed on comparison of CFU of S. Epidermis in light and UV conditions where a 34±5%
(average ± SEM) reduction was observed in bacteria exposed to UV light. This was concluded using a total of n = 86 readings. This shows that the organisms are behaving in the same manner towards the different lighting conditions, which is consistent with previous findings demonstrated in Protocol I.
[000140] Moreover, the impact of distance was explored using E. Coli K12 as a typical model organism and it was determined that the distance between the lamp and petri dish impacted the percentage growth (see above). This graph concludes the findings of n = 207 readings. The closer the lamp to the petri dish, the more intense the reduction observed (graph 1). The average SEM levels for these measurements was 4% which shows that there may be some overlap between readings when considering closer distances e.g. from 26cm to 22cm. Overall graph 1 reveals a negative linear trend demonstrating the closer the lamp to the petri dish the more reduction observed. The regression value of the light conditions (blue) show a trend of R2 = 0.9993. The closer the value is to 1 the stronger the relationship between these points. This demonstrates that the distance from the lamp is dependent on bacterial growth.
[000141] Iteration measurements
[000142] Moreover, using 10 iterations of the protocol described above we, observed a 6% reduction in bacterial load, on comparison of the bacteria exposed to UV light compared to the dark. This was using E. Coli K12 as a typical model with n = 10 readings. This shows that differences are observed with less exposure time to the UV light using this pulse sequence and power levels.
[000143] Response Modelling for Cross Contamination Risks
[000144] With the acquisition of the aforementioned data, models can be fit in order to assess cross contamination risks. We used the exponential model described above in order to assess the impact of the pulsed UV at 32 cm using 39 iterations. Using E. Coli K12 which provides a value of k = 9.7 x 10"9 (Du Pont, L. H. et al. (1971) Pathogenesis of Escherichia coli Diarrhea. The New England Journal of Medicine 285 1-9) we observed that the pulsing programme with the UVA and UVC results in a 50% decrease in cross contamination risk for E. Coli K12.
[000145] The above technology shows potential applicability to RNA which is specifically important for viruses. The effectiveness of UV has been demonstrated in other virus models such as influenza (Nishisaka-Nonaka, R. et al. (2018) Irradiation by ultraviolet light-emitting diodes inactivates influenza a viruses by inhibiting replication and transcription of viral RNA in host cells Journal of Photochemistry and Photobiology B: Biology 189 193-200). It has recently been demonstrated that coronavimses, specifically MERS-CoV, are also impacted by UV-light and are inactivated following exposure to UV light (Keil, S. D. Bowen, R. and Marschner, S. (2016) Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment. Transfusion 562948-2952).
[000146] Herein, it has been demonstrated that a pulsed UVA and UVC sequence has the capability to reduce bacterial loadings, using specifically E. Coli K12, S. Epidermis and B. Subtilis. A reduction in ATP was observed considering 12-hour exposure times using UVA and UVC to all strains using different combinations of power levels, more specifically 65 mW (UVC), 42mW(UVA) and 117mW (UVC). Moreover, pulse experiments using UVA at 42mW and UVC at 65 mW revealed a reduction in E. Coli K12 and S. Epidermis at a 32cm distance comparatively to natural light and dark settings. Moreover, distance of the UV lamp was revealed to impact the bacterial growth and an R2 = 0.9993 was obtained demonstrating this relationship. Modelling revealed a 50% reduction in cross contamination risk.
[000147] As many changes can be made to the preferred embodiment of the disclosure without departing from the scope thereof; it is intended that all matter contained herein be considered illustrative and not in a limiting sense.

Claims

CLAIMS:
1. A UVA/UVC system for reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said system comprises: i) at least one UV A light source; ii) at least one UVC light source; and iii) at least one controller connected to each of said at least one UVA light source and said at least one UVC light source, for controlling at least one parameter of each of said UVA light source and UVC light source selected from light source, light intensity, radiated power level, wavelength, exposure time and combinations thereof; wherein said at least one UVC light source emits UVC light to a surface for a period of time reducing the level of said harmful entity on said surface to a level that is safe to humans, and said at least one UVA light source emits UVA light to a surface for a period of time inhibiting growth of said harmful entity on said surface, such that during the time said at least one UVC light source and said at least one UVA light source is emitting on said surface, radiation levels from said at least one UVC light source and said at least one UVA light source is safe to humans; wherein when said at least one UVC light source is emitting UVA light to said surface, said at least one UVC light is off, and when said at least one UVA light source is emitting light to aid surface, said at least one UVC light source is off; wherein cycling between said at least one UVC light source and said at least one UVA light source is controlled by said at least one controller.
2. The system of claim 1, wherein said at least one UVC light source has an operating wavelength of from about 275 nanometers (nm) to about 295 nm. In one alternative, said at least one UVC light source has an operating wavelength of about 275 nm.
3. The system of claim 1 or 2, wherein said at least one UVA light source has an operating wavelength of from about 385 nm to about 405 nm. In one alternative, said at least one UVA light source has an operating wavelength of about 405 nm.
4. The system of any one of claims 1 to 3, wherein said at least one UVC light source is a light emitting diode (LED).
5. The system of any one of claims 1 to 4, wherein said at least one UVA light source is a LED.
6. The system of any one of claims 1 to 5, wherein the at least one controller automatically cycles between emitting light from said at least one UVA light source and from said at least one UVC light source.
7. The system of any one of claims 1 to 6, wherein said at least one UVC light source has an emission at a power level and time duration to reduce at least one pathogen on a surface exposed to said at least one UVC light source.
8. The system of any one of claims 1 to 7, wherein the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.
9. The system of any one of claims 1 to 8, wherein the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.
10. The system of any one of claims 1 to 9, wherein said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.
11. The system of any one of claims 1 to 11, wherein said at least one UVC light source has a power rating of from about 10 mW to about 100 W.
12. The system of claim 11, wherein said at least one UVC light source has a power rating of 244 mW.
13. The system of anyone of claims 1 to 12, wherein said at least one UVA light source has a power rating of from about 10 mW to about 100 W.
14. The system of claim 13, wherein said at least one UVA light source has a power rating of 20 mW.
15. The system of any one of claims 1 to 14, wherein said system reduces the level of at least one pathogen on a surface exposed to said system by 1 to 100%. In one alternative, by 10 to 20%.
16. A method of reducing levels, on a surface, and inhibiting further growth of at least one pathogen on said surface, wherein said method has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein said method comprises: i) exposing said surface to at least one UVC light source for a period of time to reduce the level of least one pathogen on said surface; ii) terminating the exposure of the at least one UVC light source on said surface; iii) exposing said UVC exposed surface to at least one UVA light source for a period of time to inhibit growth of least one pathogen on said surface; iv) terminating the exposure of the at least one UVA light source on said surface; v) optionally repeating steps i) to iv) in order to maintain a desired level of least one pathogen on said surface.
17. The method of claim 16, wherein said at least one UVC light source has an operating wavelength of from about 275 nanometers (nm) to about 295 nm.
18. The method of claim 17, wherein said at least one UVC light source has an operating wavelength of about 275 nm
19. The method of any one of claims 16 to 18, wherein said at least one UVA light source has an operating wavelength of from about 385 nm to about 405 nm.
20. The method of claim 19, wherein said at least one UVA light source has an operating wavelength of about 405 nm
21. The method of any one of claims 16 to 20, wherein said at least one UVC light source is a light emitting diode (LED).
22. The method of any one of claims 16 to 21, wherein said at least one UVA light source is a LED.
23. The method of any one of claims 16 to 22, wherein steps i) to iv) are controlled by at least one controller automatically cycling between emitting light from said at least one UVA light source and from said at least one UVC light source.
24. The method of any one of claims 16 to 23, wherein said at least one UVC light source has an emission at a power level and time duration to reduce at least one pathogen on a surface exposed to said at least one UVC light source.
25. The method of any one of claims 16 to 24, wherein the power level is selected to ensure the radiated emission from said at least one UVC light source is at a safe level for human eyes and epidermis and dermis.
26. The method of any one of claims 16 to 25, wherein the time duration is selected to ensure the radiated emission from said at least one UVC light source is at a safe exposure time for human eyes and epidermis and dermis.
27. The method of any one of claims 16 to 26, wherein said at least one UVA light source has an emission at a power level to inhibit growth of at least one pathogen on a surface exposed to said at least one UVC light source, while safe for human eyes and epidermis and dermis, regardless of the exposure time.
28. The method of any one of claims 16 to 27, wherein said at least one UVC light source has a power rating of from about 10 mW to about 100 W.
29. The method of claim 28, wherein said at least one UVC light source has a power rating of 244 mW.
30. The method of any one of claims 16 to 29, wherein said at least one UVA light source has a power rating of from about 10 mW to about 100 W.
31. The method of claim 30, wherein said at least one UVA light source has a power rating of 20 mW.
32. The method of any one of claims 16 to 31, wherein said method reduces the level of at least one pathogen on a surface by 1 to 100%.
33. The method of claim 32 wherein said level is reduced by 10 to 20%.
34. The system of any one of claims 1-15, for the reduction of at least one pathogen selected from the group consisting of E. Coli K12, S. Epidermis and B. Subtilis.
35. The method of any one of claims 16-33, for the reduction of at least one pathogen selected from the group consisting of E Coli K12, S. Epidermis and B. Subtilis.
PCT/CA2020/051059 2020-03-03 2020-07-31 Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens WO2021174331A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA3172386A CA3172386A1 (en) 2020-03-03 2020-07-31 Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens
JP2022552252A JP2023526715A (en) 2020-03-03 2020-07-31 Pathogen reduction/growth suppression system using combined ultraviolet light A (UVA) and ultraviolet light C (UVC)
KR1020227034267A KR20220149731A (en) 2020-03-03 2020-07-31 Ultraviolet A (UVA) and Ultraviolet C (UVC) Combination System for Pathogen Growth Reduction and Inhibition
EP20922533.3A EP4114472A4 (en) 2020-03-03 2020-07-31 Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens
PCT/CA2021/050543 WO2021223012A1 (en) 2020-05-04 2021-04-20 Ultra-violet a (uva) and ultra-violet c (uvc) system and methods for inactivation, reduction and inhibition of growth of coronavirus
CA3177202A CA3177202A1 (en) 2020-05-04 2021-04-20 Ultra-violet a (uva) and ultra-violet c (uvc) system and methods for inactivation, reduction and inhibition of growth of coronavirus
US17/299,378 US20230063654A1 (en) 2020-03-03 2021-04-20 Ultra-violet a (uva) and ultra-violet c (uvc) system and methods for inactivation, reduction and inhibition of growth of coronavirus
EP21799470.6A EP4146289A1 (en) 2020-05-04 2021-04-20 Ultra-violet a (uva) and ultra-violet c (uvc) system and methods for inactivation, reduction and inhibition of growth of coronavirus
ZA2022/09673A ZA202209673B (en) 2020-03-03 2022-08-30 Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202062984360P 2020-03-03 2020-03-03
US62/984,360 2020-03-03
US202063019534P 2020-05-04 2020-05-04
US63/019,534 2020-05-04

Publications (1)

Publication Number Publication Date
WO2021174331A1 true WO2021174331A1 (en) 2021-09-10

Family

ID=77556663

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2020/051059 WO2021174331A1 (en) 2020-03-03 2020-07-31 Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens

Country Status (7)

Country Link
US (1) US20210275705A1 (en)
EP (1) EP4114472A4 (en)
JP (1) JP2023526715A (en)
KR (1) KR20220149731A (en)
CA (1) CA3172386A1 (en)
WO (1) WO2021174331A1 (en)
ZA (1) ZA202209673B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180055959A1 (en) * 2016-08-24 2018-03-01 The Boeing Company Multi-wavelength ultraviolet light sanitizing systems and methods
US20180193502A1 (en) * 2017-01-12 2018-07-12 UD Innovations, LLC Portable uv-c disinfection apparatus, method, and system
WO2019072205A1 (en) * 2017-10-11 2019-04-18 The Hong Kong University Of Science And Technology Asynchronous intermittent lighting for rapid surface disinfection
US20190117811A1 (en) * 2017-10-25 2019-04-25 Sensor Electronic Technology, Inc. Illuminator with Ultraviolet and Blue-Ultraviolet Light Source
WO2020036471A1 (en) * 2018-08-17 2020-02-20 서울바이오시스 주식회사 Medical dressing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8330121B2 (en) * 2011-05-03 2012-12-11 Verilux, Inc. Dynamic display and control of UV source for sanitization in mobile devices
KR101851368B1 (en) * 2014-09-18 2018-04-23 제넥스 디스인펙션 서비시즈, 엘엘씨 Room and area disinfection utilizing pulsed light with modulated power flux and light systems with visible light compensation between pulses
US10960090B2 (en) * 2015-03-18 2021-03-30 Current Lighting Solutions, Llc Light disinfection system and method
US11071853B2 (en) * 2017-06-21 2021-07-27 Uv Light Care, Inc. System and method for sterilization using ultraviolet radiation
US12048853B2 (en) * 2018-08-14 2024-07-30 Seoul Viosys Co., Ltd. Light irradiation apparatus

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180055959A1 (en) * 2016-08-24 2018-03-01 The Boeing Company Multi-wavelength ultraviolet light sanitizing systems and methods
US20180193502A1 (en) * 2017-01-12 2018-07-12 UD Innovations, LLC Portable uv-c disinfection apparatus, method, and system
WO2019072205A1 (en) * 2017-10-11 2019-04-18 The Hong Kong University Of Science And Technology Asynchronous intermittent lighting for rapid surface disinfection
US20190117811A1 (en) * 2017-10-25 2019-04-25 Sensor Electronic Technology, Inc. Illuminator with Ultraviolet and Blue-Ultraviolet Light Source
WO2020036471A1 (en) * 2018-08-17 2020-02-20 서울바이오시스 주식회사 Medical dressing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
See also references of EP4114472A4 *
SONG, K ET AL.: "Microorganisms inactivation by wavelength combinations of ultraviolet light-emitting diodes (UV-LEDs", SCIENCE OF THE TOTAL ENVIRONMENT, vol. 665, 15 May 2019 (2019-05-15), pages 1103 - 1110, XP055822169, DOI: 10.1016/j.scitotenv.2019.02.041 *
XIAO, Y ET AL.: "Impact of UVA pre-radiation on UVC disinfection performance: Inactivation, repair and mechanism study", WATER RESEARCH, vol. 141, 2018, pages 279 - 288, XP085974117, DOI: 10.1016/j.watres.2018.05.021 *

Also Published As

Publication number Publication date
KR20220149731A (en) 2022-11-08
JP2023526715A (en) 2023-06-23
CA3172386A1 (en) 2021-09-10
US20210275705A1 (en) 2021-09-09
EP4114472A1 (en) 2023-01-11
ZA202209673B (en) 2022-11-30
EP4114472A4 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
Li et al. Comparison of UV-LED and low pressure UV for water disinfection: Photoreactivation and dark repair of Escherichia coli
Chiappa et al. The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review
Cutler et al. Ultraviolet irradiation and the mechanisms underlying its inactivation of infectious agents
Kim et al. Inactivation modeling of human enteric virus surrogates, MS2, Qβ, and ΦX174, in water using UVC-LEDs, a novel disinfecting system
US20090250626A1 (en) Liquid sanitization device
Demeersseman et al. Shedding a light on ultraviolet-C technologies in the hospital environment
CA2763710A1 (en) Portable antimicrobial ultra violet sterilizer
JP2004275335A (en) Optical sterilization method by scintillation pulse and its apparatus
FI20175639A1 (en) System and method for controlling growth of microorganisms
JP2014136113A (en) Ultraviolet ray sterilization method
Lang et al. Ultra-high irradiance (UHI) blue light: Highlighting the potential of a novel LED-based device for short antifungal treatments of food contact surfaces
WO2021174331A1 (en) Combination ultra-violet a (uva) and ultra-violet c (uvc) system for reduction and inhibition of growth of pathogens
Tsunedomi et al. UVA‐LED device to disinfect hydroponic nutrient solution
Hönes et al. Visible optical radiation generates bactericidal effect applicable for inactivation of health care associated germs demonstrated by inactivation of E. coli and B. subtilis using 405 nm and 460 nm light emitting diodes
Sun et al. Novel measurement system for linear array type uvc germicidal system
JP2020517231A (en) Accelerated oxidation treatment for microbial reduction
Holtkamp et al. Ultraviolet C (UVC) Standards and Best Practices for the Swine Industry
Malik et al. Comparison of standard light-emitting diode (LED) and 385 nm ultraviolet A LED (UVA-LED) for disinfection of Escherichia coli
Kaur et al. Assessment of Escherichia coli reactivation after photocatalytic water disinfection using flow cytometry: comparison with a culture-based method
Malik et al. Effects of ultraviolet light-emitting diodes (UVA-LEDs) irradiation on Escherichia coli for inactivation of microorganisms
Seme et al. Blue light‐emitting diodes for disinfection: Is the process able to improve hygiene in clinics and public buildings?
Mori et al. Effects of ultraviolet LED on bacteria
Narouei et al. Effects of Germicidal Far-UVC on Indoor Air Quality in an Office Setting
Rufyikiri et al. Germicidal efficacy of continuous and pulsed ultraviolet-C radiation on pathogen models and SARS-CoV-2
Tjampakasari et al. The Effectiveness of The Disinfection Tools of Ultraviolet Radiation Method in Reducing Number of Airborne Microbial in Several Indoors in

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20922533

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 3172386

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 202217048590

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2022552252

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20227034267

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020922533

Country of ref document: EP

Effective date: 20221004